Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2013);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;21191;Pharmacological Reviews;journal;15210081, 00316997;12.114;Q1;210;38;92;13930;2341;91;20.87;366,58;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
2;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.782;Q1;193;27;61;3273;1515;61;21.48;121,22;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
3;4700152457;Nano Today;journal;17480132;7.372999999999999;Q1;119;62;195;5114;2320;124;18.30;82,48;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;20425;Nature Reviews Drug Discovery;journal;14741776;7.2829999999999995;Q1;289;214;728;7324;7570;415;20.00;34,22;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;5.425;Q1;201;91;259;5973;2810;241;10.90;65,64;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;18017;Neuropsychopharmacology;journal;0893133X;5.27;Q1;204;293;837;16092;7157;744;8.01;54,92;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.414;Q1;278;168;424;21777;6023;377;14.90;129,63;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
8;12611;Drug Resistance Updates;journal;13687646, 15322084;3.734;Q1;100;10;72;1170;829;67;11.45;117,00;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;21195;Pharmacology and Therapeutics;journal;01637258;3.622;Q1;180;105;316;21154;3024;311;9.24;201,47;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.339;Q1;194;315;912;36714;5890;895;6.44;116,55;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;12455;Molecular Therapy;journal;15250024, 15250016;3.319;Q1;158;265;841;10398;5419;694;7.52;39,24;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
12;26371;Natural Product Reports;journal;02650568, 14604752;3.094;Q1;157;66;240;11257;2393;231;10.52;170,56;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
13;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.015;Q1;166;178;581;7308;3087;559;5.39;41,06;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;18148;Pain;journal;03043959;2.987;Q1;238;409;1209;19157;6790;895;7.06;46,84;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
15;4400151524;Particle and Fibre Toxicology;journal;17438977;2.8569999999999998;Q1;83;64;126;3015;1246;120;8.12;47,11;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
16;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.7460000000000004;Q1;119;35;90;7834;748;85;8.46;223,83;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
17;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2.6430000000000002;Q1;173;215;880;5464;5229;755;7.01;25,41;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
18;19427;Advances in Pharmacology;book series;10543589;2.633;Q1;68;40;106;3814;515;84;5.84;95,35;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
19;24749;Addiction Biology;journal;13556215, 13691600;2.612;Q1;70;104;201;4875;1084;198;5.08;46,88;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
20;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.537;Q1;110;624;1320;29068;7023;1290;5.05;46,58;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
21;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.516;Q1;186;213;673;10303;3234;651;4.58;48,37;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
22;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.479;Q1;172;510;1532;13844;7746;1211;6.28;27,15;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
23;5100155080;Neurotherapeutics;journal;19337213;2.471;Q1;100;71;190;6671;1188;175;4.76;93,96;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
24;23010;Journal of Controlled Release;journal;01683659;2.441;Q1;237;404;1566;21601;10704;1479;6.86;53,47;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
25;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.44;Q1;127;144;402;6910;1919;380;4.92;47,99;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
26;20435;Neuropharmacology;journal;00283908;2.428;Q1;150;443;965;31066;4815;941;5.20;70,13;United Kingdom;Elsevier Ltd.;1962-ongoing;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
27;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.423;Q1;232;982;2805;32444;13804;2612;5.07;33,04;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
28;20681;Current Opinion in Pharmacology;journal;14714892;2.355;Q1;120;142;339;7787;1879;312;4.85;54,84;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
29;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.298;Q1;240;821;2438;40807;14582;2378;5.88;49,70;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
30;20084;British Journal of Pharmacology;journal;00071188;2.283;Q1;190;442;1542;29642;8174;1467;5.31;67,06;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
31;15576;European Neuropsychopharmacology;journal;0924977X;2.2119999999999997;Q1;100;196;305;9916;1638;293;5.56;50,59;Netherlands;Elsevier BV;1990-ongoing;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
32;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;2.1790000000000003;Q1;106;142;369;6180;3089;360;7.44;43,52;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
33;110172;Progress in Drug Research;book series;0071786X;2.162;Q1;38;0;15;0;70;13;5.38;0,00;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
34;20624;Clinical Pharmacokinetics;journal;03125963;2.14;Q1;150;78;182;5515;1298;166;6.42;70,71;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;2.121;Q1;93;204;379;11407;1868;358;4.79;55,92;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
36;21782;Psychopharmacology;journal;00333158;2.121;Q1;181;410;1111;24677;4791;1043;4.41;60,19;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
37;22072;Current Gene Therapy;journal;15665232;2.0469999999999997;Q1;65;46;143;4073;757;126;6.13;88,54;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
38;5400152706;Nanotoxicology;journal;17435390, 17435404;2.046;Q1;72;81;171;3906;1191;165;6.83;48,22;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
39;21354;Expert Opinion on Therapeutic Targets;journal;14728222;2.023;Q1;78;131;362;11735;1728;355;4.96;89,58;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
40;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.02;Q1;161;213;854;9911;4669;847;5.31;46,53;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
41;21196;Drug Discovery Today;journal;13596446;2.02;Q1;157;160;452;9878;3030;419;6.51;61,74;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
42;21000196010;Topics in antiviral medicine;journal;21615853;2.0;Q1;37;15;63;361;312;61;5.20;24,07;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
43;20063;Biochemical Pharmacology;journal;00062952;1.996;Q1;181;360;1136;21302;5972;1004;5.84;59,17;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
44;23916;Environmental Pollution;journal;02697491, 18736424;1.976;Q1;194;496;1410;23328;6573;1361;4.48;47,03;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
45;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.9480000000000002;Q1;98;48;124;5822;857;113;6.97;121,29;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
46;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.903;Q1;110;459;848;23107;4762;824;5.58;50,34;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
47;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.8769999999999998;Q1;209;269;1221;12108;5460;1188;4.44;45,01;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
48;26380;Drug and Alcohol Dependence;journal;03768716;1.83;Q1;151;419;889;20504;3476;863;3.70;48,94;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
49;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.8019999999999998;Q1;89;55;252;2209;1034;243;4.09;40,16;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
50;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.776;Q1;143;308;773;13352;2836;718;3.68;43,35;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
51;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;1.754;Q1;58;5;10;931;41;10;4.10;186,20;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
52;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.7519999999999998;Q1;114;245;789;16770;3092;649;4.79;68,45;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
53;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.739;Q1;89;33;96;4051;587;92;6.29;122,76;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
54;25218;Toxicological Sciences;journal;10960929, 10966080;1.7380000000000002;Q1;164;271;870;13101;4202;814;5.08;48,34;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
55;21165;PharmacoEconomics;journal;11707690;1.713;Q1;91;100;290;4647;1007;243;4.07;46,47;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
56;21169;Pharmacological Research;journal;10436618, 10961186;1.702;Q1;118;131;434;9279;2287;421;4.77;70,83;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
57;144771;Clinical Trials;journal;17407753, 17407745;1.683;Q1;55;110;251;2590;494;207;1.86;23,55;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
58;19600166320;Protein & Cell;journal;16748018, 1674800X;1.6540000000000001;Q1;48;109;379;5193;1098;348;2.88;47,64;Germany;Springer Verlag;2010-ongoing;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
59;19700176055;F1000 Biology Reports;journal;17404118;1.635;Q1;27;2;138;163;383;137;4.64;81,50;United Kingdom;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q2); Neuroscience (miscellaneous) (Q2)"
60;28792;Cancer Biology and Therapy;journal;15384047;1.631;Q1;101;155;798;6312;2820;676;4.06;40,72;United States;Landes Bioscience;2002-ongoing;"Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2)"
61;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.615;Q1;70;16;75;2202;391;69;5.60;137,63;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
62;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.6030000000000002;Q1;59;155;301;5823;1231;245;4.62;37,57;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
63;23109;Journal of Psychopharmacology;journal;02698811;1.5919999999999999;Q1;106;134;581;8175;2141;543;3.99;61,01;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
64;29311;Current Cancer Drug Targets;journal;15680096;1.585;Q1;85;82;270;8657;1035;249;4.10;105,57;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Cancer Research (Q2)"
65;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.581;Q1;102;136;356;6673;1519;350;4.05;49,07;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
66;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.57;Q1;191;271;828;11359;4224;779;4.84;41,92;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
67;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.5659999999999998;Q1;138;283;631;11379;3178;621;4.96;40,21;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
68;21100207003;Theranostics;journal;18387640;1.56;Q1;69;95;106;5591;810;96;8.44;58,85;Canada;Ivyspring International Publisher;2012-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
69;21100225611;Advanced healthcare materials;journal;21922640, 21922659;1.557;Q1;63;183;93;9110;428;92;4.65;49,78;United Kingdom;John Wiley and Sons Ltd;2012-ongoing;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
70;21790;Antiviral Therapy;journal;13596535;1.554;Q1;78;136;501;4648;1603;467;3.40;34,18;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
71;20664;Current Drug Targets;journal;13894501;1.548;Q1;92;176;548;14997;2197;496;4.09;85,21;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
72;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.527;Q1;144;200;726;10112;3033;693;4.49;50,56;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
73;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;1.52;Q1;64;232;372;9207;2668;367;7.77;39,69;United States;American Scientific Publishers;2007-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
74;24763;Addictive Behaviors;journal;03064603;1.516;Q1;114;239;672;10217;2146;666;2.86;42,75;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
75;19617;Antiviral Research;journal;01663542;1.516;Q1;108;245;545;14969;2398;527;3.81;61,10;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
76;23053;Journal of Natural Products;journal;01633864, 15206025;1.5119999999999998;Q1;124;349;1160;11301;4681;1125;4.39;32,38;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
77;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.508;Q1;30;47;69;1069;300;63;5.91;22,74;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
78;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.5030000000000001;Q1;78;75;173;3320;904;166;5.43;44,27;United Kingdom;Nature Publishing Group;2001-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
79;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.489;Q1;94;141;461;10891;1967;441;4.49;77,24;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
80;84948;Expert Opinion on Drug Delivery;journal;17425247;1.482;Q1;88;129;329;11044;1719;325;4.59;85,61;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
81;19600166302;Current molecular pharmacology;journal;18744702;1.455;Q1;34;20;71;1907;252;65;3.24;95,35;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
82;18071;Neurotoxicity Research;journal;10298428;1.44;Q1;65;81;244;6046;890;238;3.58;74,64;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
83;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.431;Q1;153;381;915;19828;4091;887;4.09;52,04;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
84;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.425;Q1;52;231;506;5544;1757;491;3.30;24,00;United States;American Chemical Society;2010-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
85;16836;BMC Chemical Biology;journal;14726769;1.4180000000000001;Q1;19;0;14;0;45;14;1.14;0,00;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q1); Molecular Medicine (Q2)"
86;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.4180000000000001;Q1;44;103;264;5968;864;248;2.99;57,94;United States;Springer New York LLC;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
87;4000148019;AAPS Journal;journal;15507416;1.4169999999999998;Q1;96;123;252;5696;1167;235;4.37;46,31;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
88;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.411;Q1;161;254;876;9884;3436;853;3.78;38,91;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
89;21237;Drug Safety;journal;01145916;1.382;Q1;115;117;311;5288;1062;251;3.19;45,20;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
90;20783;Expert Review of Vaccines;journal;14760584;1.381;Q1;75;144;467;10084;1664;380;4.02;70,03;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
91;22454;International Journal of Pharmaceutics;journal;03785173;1.3769999999999998;Q1;190;828;2058;33247;9262;2010;4.42;40,15;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
92;23488;Current Medicinal Chemistry;journal;09298673;1.3730000000000002;Q1;158;361;1229;41645;5429;1165;4.27;115,36;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
93;22378;Vascular Pharmacology;journal;15371891;1.368;Q1;86;71;180;4339;778;166;5.36;61,11;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
94;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.3619999999999999;Q1;82;57;159;1995;472;157;2.91;35,00;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
95;19700174918;Clinical and Translational Science;journal;17528062, 17528054;1.3530000000000002;Q1;35;83;255;1714;515;178;2.85;20,65;United States;Wiley-Blackwell;2008-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
96;21100214102;Frontiers in Pharmacology;journal;16639812;1.3519999999999999;Q1;62;151;337;11092;1201;331;3.76;73,46;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
97;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.347;Q1;81;78;375;8443;1458;350;4.05;108,24;Germany;Springer Verlag;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2)"
98;25075;Ecotoxicology;journal;09639292, 15733017;1.3359999999999999;Q1;81;141;600;7579;1799;589;2.75;53,75;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
99;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.306;Q1;55;62;209;1908;515;139;3.31;30,77;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
100;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;1.2990000000000002;Q1;44;69;159;2448;483;152;3.61;35,48;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
101;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.297;Q1;100;429;976;19127;4820;958;4.90;44,59;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Nanoscience and Nanotechnology (Q2)"
102;20682;Current Pharmaceutical Design;journal;13816128;1.295;Q1;140;662;1403;71275;5262;1285;3.84;107,67;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
103;13250;Expert Opinion on Biological Therapy;journal;14712598;1.288;Q1;75;167;484;12106;1921;465;4.12;72,49;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
104;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.287;Q1;78;140;309;10449;973;270;3.02;74,64;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
105;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.2819999999999998;Q1;81;90;238;3403;660;216;3.36;37,81;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
106;24604;Archives of Toxicology;journal;14320738, 03405761;1.281;Q1;96;185;445;12348;1971;378;5.20;66,75;Germany;Springer Verlag;1972-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
107;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.281;Q1;126;250;773;13552;2417;764;3.19;54,21;United States;Elsevier Inc.;1973-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q3)"
108;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.272;Q1;131;281;696;11729;2318;534;4.20;41,74;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
109;12331;Current Topics in Medicinal Chemistry;journal;15680266;1.268;Q1;104;242;606;23710;2293;526;4.12;97,98;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
110;23079;Journal of Pharmaceutical Sciences;journal;00223549;1.2670000000000001;Q1;159;417;1358;16968;5040;1278;3.72;40,69;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
111;145164;Human Genomics;journal;14739542, 14797364;1.266;Q1;49;24;99;1098;306;88;3.38;45,75;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
112;20679;Current Opinion in Investigational Drugs;journal;14724472;1.265;Q1;71;0;145;0;537;143;0.00;0,00;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
113;19034;Microbial Drug Resistance;journal;10766294;1.265;Q1;62;82;215;3047;657;214;2.91;37,16;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
114;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.264;Q1;64;110;223;8448;746;207;2.95;76,80;Germany;Springer Verlag;2006-ongoing;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2)"
115;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.263;Q1;116;113;343;4868;862;326;2.61;43,08;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
116;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;1.258;Q1;43;94;251;1744;272;226;0.81;18,55;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
117;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.252;Q1;27;19;36;835;100;35;2.86;43,95;Netherlands;Elsevier BV;2011-ongoing;"Infectious Diseases (Q1); Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
118;25219;Toxicology;journal;0300483X;1.239;Q1;143;237;641;12603;2758;598;4.17;53,18;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
119;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1.235;Q1;114;442;1415;12267;4900;1396;3.33;27,75;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
120;19700175004;Open Medicinal Chemistry Journal;journal;18741045;1.227;Q1;15;7;23;247;106;21;4.75;35,29;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
121;17464;European Journal of Medicinal Chemistry;journal;02235234;1.216;Q1;135;713;2055;29010;8777;2044;3.77;40,69;Netherlands;Elsevier BV;1974-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
122;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.212;Q1;60;0;88;0;343;87;0.00;0,00;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
123;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.199;Q1;75;0;70;0;276;67;0.00;0,00;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
124;18966;Mutagenesis;journal;02678357, 14643804;1.195;Q1;82;85;272;3765;1020;259;3.86;44,29;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
125;21353;Expert Opinion on Therapeutic Patents;journal;13543776;1.188;Q1;61;112;331;9802;1162;324;3.48;87,52;United Kingdom;Taylor & Francis;1991-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
126;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;1.188;Q1;61;42;137;1468;489;129;3.00;34,95;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
127;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1.182;Q1;54;211;507;11482;1474;402;3.57;54,42;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
128;25125;Journal of Analytical Toxicology;journal;01464760;1.17;Q1;69;102;285;2400;768;269;2.97;23,53;United States;Perston Publications, Inc.;1977-ongoing;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
129;4000148406;Clinical Toxicology;journal;15563650;1.163;Q1;85;170;471;2993;1230;370;3.59;17,61;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
130;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.162;Q1;36;24;78;3422;229;71;3.12;142,58;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
131;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.16;Q1;50;103;274;10456;983;272;3.68;101,51;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q1)
132;16088;Journal of Nanobiotechnology;journal;14773155;1.1540000000000001;Q1;57;52;138;1694;712;136;4.95;32,58;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
133;23015;Journal of Ethnopharmacology;journal;03788741;1.153;Q1;170;640;1965;29626;7588;1935;3.67;46,29;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
134;4400151608;ChemMedChem;journal;18607187, 18607179;1.147;Q1;92;241;673;9068;2087;638;3.27;37,63;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
135;22477;Investigational New Drugs;journal;01676997, 15730646;1.1440000000000001;Q1;80;188;581;6024;1834;564;3.36;32,04;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
136;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.1440000000000001;Q1;40;31;94;2319;390;86;4.87;74,81;United Kingdom;SAGE Publications;2008-ongoing;"Pharmacology (Q1); Neurology (Q2); Neurology (clinical) (Q2)"
137;20663;Current Drug Metabolism;journal;13892002;1.138;Q1;97;102;304;10586;1271;266;4.11;103,78;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmacology (Q1); Clinical Biochemistry (Q2)"
138;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.125;Q1;76;80;265;4311;648;261;2.39;53,89;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
139;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.122;Q1;82;174;322;13259;998;287;3.16;76,20;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
140;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.122;Q1;100;331;898;10432;2832;877;3.13;31,52;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
141;20027;BMC Pharmacology;journal;14712210;1.12;Q1;38;0;39;0;143;38;2.91;0,00;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
142;25240;Toxicology Letters;journal;03784274;1.11;Q1;129;276;931;12068;3508;909;3.73;43,72;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
143;26512;Tetrahedron;journal;00404020;1.1059999999999999;Q1;209;1341;3674;67243;10894;3621;3.03;50,14;United Kingdom;Elsevier Ltd.;1957-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
144;24652;Chemico-Biological Interactions;journal;00092797;1.097;Q1;108;258;666;10676;2338;636;3.37;41,38;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
145;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.089;Q1;39;72;191;3141;604;178;3.05;43,63;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
146;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.082;Q1;67;58;148;3592;445;144;3.24;61,93;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
147;21333;European Journal of Pharmacology;journal;00142999;1.068;Q2;167;697;2047;33525;6526;2025;3.10;48,10;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
148;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.064;Q1;142;846;2455;33181;8038;2415;3.13;39,22;United Kingdom;Elsevier Ltd.;1993-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
149;4400151410;Human Vaccines;journal;15548600, 15548619;1.062;Q1;49;0;450;0;1142;324;3.62;0,00;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
150;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;1.062;Q1;43;78;64;3059;161;52;3.10;39,22;United States;Cell Press;2012-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2)"
151;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;1.057;Q1;99;73;332;4026;1039;326;3.12;55,15;Netherlands;Elsevier BV;2000-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
152;19700188352;Toxins;journal;20726651;1.053;Q1;56;179;335;11247;1165;331;2.94;62,83;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
153;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;1.048;Q1;37;104;278;5067;763;235;2.75;48,72;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q1); Drug Discovery (Q1); Clinical Biochemistry (Q2)"
154;22983;Journal of Clinical Pharmacology;journal;00912700;1.047;Q2;106;165;564;5192;1640;528;2.92;31,47;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
155;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.046;Q2;89;114;313;4317;783;274;2.57;37,87;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q2)"
156;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.046;Q1;61;54;139;1684;444;131;3.65;31,19;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
157;18075;Neurotoxicology and Teratology;journal;08920362;1.043;Q2;89;65;234;4497;745;221;3.45;69,18;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
158;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;1.041;Q2;60;225;553;7277;1581;544;2.61;32,34;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q2)"
159;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.04;Q1;119;260;638;11561;2372;624;3.50;44,47;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
160;24028;Reproductive Toxicology;journal;08906238;1.036;Q2;99;122;436;6274;1387;397;3.37;51,43;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q2)
161;17067;Phytomedicine;journal;09447113;1.031;Q1;105;189;585;6222;2323;575;3.56;32,92;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
162;18073;NeuroToxicology;journal;0161813X;1.0270000000000001;Q2;102;141;396;6968;1288;377;3.37;49,42;Netherlands;Elsevier BV;1979-ongoing;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
163;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.023;Q2;74;126;496;4588;1213;495;2.41;36,41;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
164;22319;Toxicon;journal;00410101;1.022;Q2;116;305;808;14039;2575;778;2.88;46,03;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
165;25096;Food and Chemical Toxicology;journal;02786915;1.02;Q2;149;814;1789;35608;6409;1737;3.12;43,74;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
166;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.02;Q1;80;96;266;5108;900;257;3.43;53,21;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
167;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1.0190000000000001;Q2;91;151;515;7252;1298;482;2.52;48,03;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
168;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.016;Q2;63;70;202;2942;536;167;3.30;42,03;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
169;15581;Current Pharmaceutical Biotechnology;journal;13892010;1.011;Q1;73;130;607;9630;1711;550;3.01;74,08;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
170;21100232818;Emerging Microbes and Infections;journal;22221751;1.001;Q1;31;42;29;1983;60;26;2.31;47,21;United Kingdom;Nature Publishing Group;2012-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Immunology (Q2); Infectious Diseases (Q2); Microbiology (Q2); Parasitology (Q2); Virology (Q2); Epidemiology (Q3)"
171;17595;Journal of Biomolecular Screening;journal;10870571;1.0;Q1;69;120;409;3935;895;396;2.15;32,79;United States;Sage Science Press;1996-ongoing;"Analytical Chemistry (Q1); Drug Discovery (Q1); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
172;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.998;Q2;70;92;259;4325;774;254;3.04;47,01;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
173;24785;Alcohol;journal;07418329;0.996;Q2;74;78;233;3498;647;228;2.42;44,85;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
174;22432;International Immunopharmacology;journal;15675769;0.9940000000000001;Q2;98;352;824;14605;2526;800;3.15;41,49;Netherlands;Elsevier BV;2001-ongoing;"Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
175;19700194010;MedChemComm;journal;20402503, 20402511;0.987;Q1;44;219;431;7796;1174;413;2.67;35,60;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
176;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.986;Q2;98;144;464;6765;1063;458;2.16;46,98;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q2)"
177;14805;Steroids;journal;0039128X;0.9840000000000001;Q2;95;181;576;7163;1789;561;3.06;39,57;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
178;21455;Progress in Medicinal Chemistry;book series;00796468;0.983;Q2;33;6;18;543;50;9;4.33;90,50;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
179;19700175230;Drug Design, Development and Therapy;journal;11778881;0.9790000000000001;Q1;48;150;119;7621;485;114;4.28;50,81;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
180;29712;Clinical Therapeutics;journal;01492918;0.977;Q2;123;221;660;7250;1889;588;3.19;32,81;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
181;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.976;Q2;33;49;179;1039;230;162;1.40;21,20;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2); Statistics and Probability (Q2)"
182;20473;Life Sciences;journal;00243205;0.968;Q1;150;309;870;14202;2413;854;2.54;45,96;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
183;19984;Assay and Drug Development Technologies;journal;1540658X;0.9640000000000001;Q2;52;85;309;2021;351;156;2.32;23,78;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
184;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.9570000000000001;Q2;95;135;507;6167;1185;454;2.72;45,68;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
185;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.9570000000000001;Q1;44;128;348;4024;943;319;3.11;31,44;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Pharmaceutical Science (Q1); Spectroscopy (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2)"
186;16533;Phytochemical Analysis;journal;09580344, 10991565;0.955;Q2;63;85;249;2520;795;246;2.85;29,65;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
187;14990;Current Neuropharmacology;journal;1570159X;0.951;Q2;58;48;174;6542;551;161;2.73;136,29;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
188;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.951;Q2;43;40;138;3787;432;134;3.51;94,68;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
189;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.94;Q2;29;18;64;2003;178;57;3.49;111,28;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
190;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.9390000000000001;Q2;79;164;355;14556;1229;337;3.67;88,76;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
191;21229;Drug News and Perspectives;journal;02140934;0.938;Q2;47;0;73;0;167;70;0.00;0,00;Spain;J.R. Prous;1990-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
192;25224;Toxicology in Vitro;journal;08872333;0.9329999999999999;Q2;96;284;706;11248;2479;696;3.44;39,61;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
193;144790;Marine Drugs;journal;16603397;0.932;Q2;84;310;521;15654;2911;520;4.46;50,50;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q2)
194;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.9309999999999999;Q1;133;1318;4678;37531;12301;4596;2.56;28,48;United Kingdom;Elsevier Ltd.;1991-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
195;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.922;Q2;22;18;55;827;96;50;0.55;45,94;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q2); Molecular Medicine (Q3)"
196;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;0.92;Q1;69;15;34;2655;131;34;4.09;177,00;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
197;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.9159999999999999;Q2;99;271;594;9148;1635;502;3.31;33,76;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
198;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.9129999999999999;Q2;89;77;312;4027;973;296;3.08;52,30;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
199;26514;Tetrahedron Letters;journal;00404039;0.9079999999999999;Q2;159;1650;5203;58788;13033;5145;2.57;35,63;United Kingdom;Elsevier Ltd.;1959-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
200;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.9059999999999999;Q2;72;128;371;11082;1272;366;3.47;86,58;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
201;4700152848;PPAR Research;journal;16874757, 16874765;0.9;Q2;40;34;166;2093;389;158;1.83;61,56;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
202;25109;Inhalation Toxicology;journal;08958378, 10917691;0.895;Q2;77;95;348;3862;796;328;2.52;40,65;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
203;25214;Toxicologic Pathology;journal;15331601, 01926233;0.894;Q2;96;100;363;4974;1074;331;2.59;49,74;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
204;6400153120;Chinese Medicine;journal;17498546;0.885;Q2;34;23;113;955;388;105;3.18;41,52;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
205;18077;Fitoterapia;journal;0367326X;0.882;Q2;90;256;686;8315;2045;682;2.76;32,48;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
206;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.878;Q2;42;53;171;3006;451;152;2.77;56,72;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
207;20051;BioDrugs;journal;11738804;0.871;Q2;60;57;136;4080;451;134;2.70;71,58;United Kingdom;Adis International Ltd.;1997-ongoing;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
208;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0.8690000000000001;Q2;83;113;336;5120;854;332;2.57;45,31;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
209;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.866;Q2;78;200;607;9273;1483;590;2.42;46,37;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
210;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;0.862;Q2;36;25;73;1805;281;72;3.56;72,20;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q1); Plant Science (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
211;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.8490000000000001;Q1;21;10;59;868;121;53;1.66;86,80;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q1); Molecular Biology (Q3)"
212;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.847;Q1;58;79;235;2830;672;200;3.70;35,82;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
213;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.8420000000000001;Q2;87;39;236;1782;566;224;2.32;45,69;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
214;26767;Altex;journal;1868596X, 18688551;0.841;Q2;45;40;103;2875;292;81;3.55;71,88;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
215;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.841;Q2;20;40;39;1618;82;39;2.10;40,45;United States;Mary Ann Liebert Inc.;2012-ongoing;"Applied Microbiology and Biotechnology (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Medicine (Q3)"
216;22410;Inflammation Research;journal;1420908X, 10233830;0.8390000000000001;Q2;82;118;454;4769;1053;442;2.31;40,42;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
217;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.836;Q2;88;127;402;4960;997;387;2.30;39,06;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
218;21167;Pharmacogenomics;journal;14622416;0.8340000000000001;Q2;83;239;575;11308;1687;477;3.09;47,31;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
219;16573;Phytotherapy Research;journal;10991573, 0951418X;0.83;Q2;112;278;986;10400;2742;948;2.64;37,41;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
220;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.83;Q2;90;142;461;6091;1247;429;2.66;42,89;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
221;4000150314;Chemical Biology and Drug Design;journal;17470277;0.821;-;71;158;514;6381;1348;494;2.61;40,39;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q2); Molecular Medicine (Q3)"
222;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.816;Q2;78;223;498;7362;1076;495;2.04;33,01;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
223;20602;Clinical Neuropharmacology;journal;03625664;0.8140000000000001;Q2;74;57;201;1443;517;189;2.28;25,32;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
224;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.812;Q2;76;169;294;8182;892;286;3.15;48,41;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
225;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.8109999999999999;Q1;79;146;530;4933;1377;522;2.30;33,79;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
226;130063;Pharmacological Reports;journal;17341140, 22995684;0.8109999999999999;Q2;71;176;464;8010;1167;447;2.48;45,51;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
227;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.809;Q2;78;116;347;4441;658;340;1.60;38,28;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
228;24071;Metal-Based Drugs;journal;07930291, 16875486;0.807;Q2;33;0;5;0;24;5;0.00;0,00;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Pharmacology (Q2); Toxicology (Q2)"
229;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.804;Q2;53;144;304;4514;591;292;1.92;31,35;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
230;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.8009999999999999;Q2;46;7;65;451;171;62;2.33;64,43;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
231;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.7979999999999999;Q2;41;75;244;1710;530;201;3.19;22,80;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
232;21744;Planta Medica;journal;14390221, 00320943;0.7979999999999999;Q1;103;222;871;7007;2298;831;2.53;31,56;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
233;22411;Inflammopharmacology;journal;09254692, 15685608;0.795;Q2;45;42;108;2606;296;99;3.49;62,05;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
234;10900153302;Biomarker Insights;journal;11772719;0.7929999999999999;Q2;24;15;53;604;142;52;2.42;40,27;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
235;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.7929999999999999;Q2;69;245;817;16067;2102;753;2.82;65,58;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
236;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.7929999999999999;Q2;18;0;16;0;35;16;3.00;0,00;United Kingdom;BioMed Central;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
237;20770;Drug Delivery;journal;10717544;0.7909999999999999;Q1;52;42;190;1506;485;180;2.60;35,86;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
238;23155;Current Vascular Pharmacology;journal;15701611;0.7829999999999999;Q2;54;95;268;10702;771;248;3.05;112,65;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
239;25093;Environmental Toxicology;journal;15227278, 15204081;0.778;Q2;69;73;226;3540;497;222;2.24;48,49;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q1); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
240;19700188217;Bioanalysis;journal;17576180, 17576199;0.775;Q1;51;319;797;8555;1918;659;2.86;26,82;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2)"
241;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.769;Q2;78;119;325;4233;810;320;2.46;35,57;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
242;20570;Chemotherapy;journal;00093157, 14219794;0.767;Q2;49;51;188;1344;385;182;2.02;26,35;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
243;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.7609999999999999;Q2;18;0;3;0;6;3;2.00;0,00;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
244;22575;Cardiovascular Toxicology;journal;15307905;0.76;Q2;47;46;123;1934;307;116;2.29;42,04;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
245;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.759;Q2;34;36;113;2679;255;105;2.52;74,42;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
246;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.7559999999999999;Q2;80;125;428;4600;1071;405;2.44;36,80;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
247;25171;Mycotoxin Research;journal;01787888;0.753;Q2;31;35;101;1171;222;100;2.05;33,46;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q2); Toxicology (Q2); Microbiology (Q3)"
248;20634;Journal of Texture Studies;journal;00224901;0.7490000000000001;Q1;48;46;148;1634;253;145;1.88;35,52;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q1); Pharmaceutical Science (Q1)"
249;21207;Drug Discovery Today: Technologies;journal;17406749;0.741;Q2;41;71;92;2938;217;82;2.39;41,38;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
250;19700178100;Nanotechnology, Science and Applications;journal;11778903;0.74;Q1;23;0;35;0;132;35;4.00;0,00;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Nanoscience and Nanotechnology (Q2)"
251;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.7290000000000001;Q1;54;48;144;1953;424;140;2.86;40,69;United States;John Wiley & Sons Inc.;1979-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
252;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.723;Q2;30;41;122;1930;299;117;2.42;47,07;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
253;26370;Molecules;journal;14203049;0.7190000000000001;Q1;116;1019;2470;45323;7136;2459;2.49;44,48;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
254;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.718;Q2;80;112;427;4733;901;410;2.13;42,26;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
255;130047;Current Drug Discovery Technologies;journal;15701638;0.7140000000000001;Q2;38;34;101;2258;271;91;2.63;66,41;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
256;15840;Journal of Antibiotics;journal;00218820;0.7120000000000001;Q2;73;126;410;3355;860;375;2.33;26,63;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
257;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.711;Q1;11;37;87;942;63;84;0.75;25,46;United Kingdom;Taylor and Francis Inc.;2011-ongoing;"Pharmaceutical Science (Q1); Statistics and Probability (Q3)"
258;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.71;Q1;104;312;1050;10186;2236;1014;2.08;32,65;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
259;14822;Xenobiotica;journal;00498254, 13665928;0.71;Q2;75;119;318;4569;760;313;2.43;38,39;United Kingdom;Taylor & Francis;1971-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
260;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.7070000000000001;Q2;49;38;140;2911;257;125;1.82;76,61;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
261;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.7070000000000001;Q2;64;75;207;3039;610;200;2.59;40,52;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
262;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.706;Q1;32;71;217;3929;443;186;2.65;55,34;United Kingdom;Taylor & Francis;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
263;21100788810;Chemotherapy Research and Practice;journal;20902115, 20902107;0.705;Q1;5;0;1;0;4;1;4.00;0,00;United States;Hindawi Limited;2011, 2014-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Oncology (Q2); Pharmacology (medical) (Q2)"
264;5800173383;Current Clinical Pharmacology;journal;15748847;0.705;Q1;33;56;104;2752;271;100;2.38;49,14;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
265;13248;Experimental and Toxicologic Pathology;journal;09402993;0.7040000000000001;Q2;58;152;304;5949;807;300;2.54;39,14;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
266;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.7020000000000001;Q2;32;47;131;2135;294;124;2.37;45,43;United States;Taylor and Francis;2004-ongoing;"Toxicology (Q2); Immunology (Q3)"
267;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.701;Q2;35;51;71;2388;194;69;2.93;46,82;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine (Q2); Pharmacology (Q2)"
268;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.6990000000000001;Q2;56;31;114;1888;281;114;2.28;60,90;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
269;23942;Biomedical Chromatography;journal;10990801, 02693879;0.698;Q2;58;244;574;6055;1183;563;1.98;24,82;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Molecular Biology (Q3)"
270;19900192900;Molecular Informatics;journal;18681751, 18681743;0.696;Q2;60;87;232;4195;602;222;2.31;48,22;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
271;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.693;Q2;54;86;297;2705;470;286;1.54;31,45;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
272;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.6920000000000001;Q2;68;44;144;2607;413;138;2.52;59,25;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
273;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.69;Q2;77;151;437;6598;839;417;1.81;43,70;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
274;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.6890000000000001;Q2;72;214;385;8772;965;382;2.24;40,99;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
275;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.687;Q2;64;76;255;3535;546;251;1.92;46,51;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
276;16948;Chirality;journal;1520636X, 08990042;0.6859999999999999;Q2;73;132;428;4850;832;423;1.80;36,74;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
277;4000151703;Core Evidence;journal;15551741, 1555175X;0.685;Q2;19;7;29;442;80;28;3.58;63,14;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
278;29053;Molecular Diversity;journal;1573501X, 13811991;0.685;Q2;54;69;263;2854;708;257;2.73;41,36;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
279;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.6809999999999999;Q2;65;98;303;2650;720;296;2.16;27,04;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
280;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.6809999999999999;Q1;107;182;573;7354;1485;565;2.53;40,41;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
281;130025;Current Drug Delivery;journal;15672018;0.677;Q1;54;80;183;2491;437;176;2.79;31,14;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
282;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.677;Q2;87;116;368;3966;787;326;2.30;34,19;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
283;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.6759999999999999;Q1;22;25;55;1114;145;53;2.43;44,56;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
284;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.6759999999999999;Q2;43;408;350;14488;513;241;2.13;35,51;United States;Landes Bioscience;2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
285;21100241601;Toxicology Research;journal;2045452X;0.66;Q3;24;40;23;2271;84;22;3.82;56,78;United Kingdom;Royal Society of Chemistry;2012-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
286;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.645;Q2;61;146;360;4916;674;349;2.12;33,67;United Kingdom;Taylor & Francis;1985-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
287;20026;BMC Clinical Pharmacology;journal;14726904;0.644;Q2;35;0;53;0;148;53;2.62;0,00;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
288;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.642;Q2;26;27;117;1349;281;113;2.62;49,96;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology (Q2); Toxicology (Q3)"
289;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.64;Q2;50;29;111;1292;217;109;2.38;44,55;United States;Elsevier Inc.;1971-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
290;24578;Mathematical Medicine and Biology;journal;14778599;0.64;Q2;40;18;45;597;87;43;1.92;33,17;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
291;19700175819;Patient Preference and Adherence;journal;1177889X;0.636;Q1;37;122;197;4909;415;191;2.01;40,24;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
292;25898;Journal of Peptide Science;journal;10752617, 10991387;0.635;Q2;60;100;315;4230;574;310;2.00;42,30;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
293;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.633;Q1;25;26;66;743;115;62;1.61;28,58;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
294;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.632;Q1;70;83;243;3244;513;242;2.18;39,08;United Kingdom;Taylor & Francis;1984-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
295;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.624;Q1;69;56;140;3727;385;140;2.30;66,55;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
296;21194;Pharmacology;journal;00317012, 14230313;0.621;Q2;54;76;272;2341;517;268;1.60;30,80;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
297;19700174889;Drug Target Insights;journal;11773928;0.614;Q1;10;6;6;212;11;6;1.83;35,33;New Zealand;Libertas Academica;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
298;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.611;Q2;30;21;98;788;167;93;1.76;37,52;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
299;23039;Journal of Liposome Research;journal;08982104, 15322394;0.608;Q1;44;37;113;1739;241;113;1.92;47,00;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
300;19700200821;Therapeutic delivery;journal;20415990, 20416008;0.608;Q1;37;138;347;8233;638;316;2.02;59,66;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science (Q1)
301;19443;American Journal of Health-System Pharmacy;journal;10792082;0.603;Q2;87;348;1169;6623;1355;648;2.08;19,03;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
302;19700175015;Infection and Drug Resistance;journal;11786973;0.601;Q2;27;27;47;1454;121;46;2.79;53,85;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
303;23412;Journal of AOAC International;journal;10603271;0.6;Q2;79;216;691;4913;1063;671;1.56;22,75;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
304;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.596;Q1;27;60;85;3560;143;77;1.86;59,33;Germany;Springer verlag;2011-ongoing;Pharmaceutical Science (Q1)
305;19700175105;Open Drug Delivery Journal;journal;18741266;0.593;Q1;5;0;8;0;10;7;0.00;0,00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science (Q1)
306;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.5920000000000001;Q2;55;98;277;3422;526;264;1.71;34,92;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
307;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.59;Q2;79;225;792;6767;1206;788;1.57;30,08;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3)"
308;17700156714;Pharmaceuticals;journal;14248247;0.59;Q1;44;72;355;7009;646;349;1.35;97,35;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q1); Molecular Medicine (Q3)"
309;19700185200;Journal of Natural Medicines;journal;18610293;0.586;Q2;37;121;282;3402;557;282;1.94;28,12;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
310;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.58;Q2;36;37;82;2080;144;79;1.68;56,22;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Hematology (Q3)"
311;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.575;Q2;21;23;74;2232;146;72;2.19;97,04;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3)"
312;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.5720000000000001;Q2;22;17;33;996;72;33;2.64;58,59;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
313;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.5670000000000001;Q2;84;191;851;5343;1540;845;1.59;27,97;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
314;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.5660000000000001;Q2;29;43;181;1029;291;169;1.46;23,93;India;Medknow Publications;2008-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
315;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.565;Q2;54;59;139;2324;255;129;1.66;39,39;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
316;16067;Reading Teacher;journal;00340561;0.563;Q3;44;79;258;1504;226;226;0.99;19,04;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (medical) (Q2); Pharmacology (Q3)"
317;19958;Archives of Pharmacal Research;journal;02536269;0.561;Q2;75;181;771;6697;1591;754;2.00;37,00;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3)"
318;21264;Drugs in R and D;journal;11745886;0.557;Q3;39;33;86;952;166;79;2.21;28,85;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q3)
319;19700175244;Current Radiopharmaceuticals;journal;18744710;0.555;Q3;21;26;107;1359;160;98;1.50;52,27;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Radiology, Nuclear Medicine and Imaging (Q2); Pharmacology (Q3)"
320;25106;Human and Experimental Toxicology;journal;09603271;0.5489999999999999;Q3;71;130;509;5892;943;474;1.79;45,32;United States;SAGE Publications;1981-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
321;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.5479999999999999;Q3;63;265;986;5978;1407;983;1.43;22,56;Germany;Springer Verlag;1966-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q3)"
322;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.547;Q3;54;48;165;1869;316;154;1.75;38,94;United States;John Wiley & Sons Inc.;2003-ongoing;"Health, Toxicology and Mutagenesis (Q2); Embryology (Q3); Toxicology (Q3); Developmental Biology (Q4)"
323;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.542;Q2;59;91;280;3712;520;255;2.26;40,79;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q3)"
324;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.541;Q2;52;151;348;3910;569;325;1.55;25,89;Germany;Springer Verlag;2010-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
325;19700174941;Pharmacognosy Research;journal;09748490, 09764836;0.54;Q2;25;51;167;1464;263;156;1.83;28,71;India;Medknow Publications;2010-ongoing;"Drug Discovery (Q2); Pharmacology (Q3)"
326;5800173386;Current Drug Safety;journal;15748863;0.539;Q3;31;50;176;1276;280;159;1.37;25,52;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
327;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.536;Q1;19;18;42;562;61;42;1.44;31,22;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
328;13671;Biologicals;journal;10958320, 10451056;0.535;Q3;51;72;268;2876;468;260;1.69;39,94;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
329;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.529;Q3;53;66;167;2668;266;166;1.46;40,42;United States;John Wiley & Sons Inc.;1998-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
330;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.526;Q3;23;75;191;3028;270;190;1.45;40,37;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q3); Physiology (Q3)"
331;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.522;Q2;54;91;267;3434;544;266;1.79;37,74;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
332;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.52;Q3;35;90;250;3916;433;241;1.77;43,51;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
333;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.518;Q3;51;67;223;2251;347;207;1.50;33,60;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
334;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.511;Q2;24;52;84;3394;162;76;2.00;65,27;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
335;17500155003;Records of Natural Products;journal;13076167;0.509;Q2;24;55;137;1149;245;136;1.46;20,89;Turkey;ACG Publications;2009-ongoing;"Drug Discovery (Q2); Plant Science (Q2); Organic Chemistry (Q3); Pharmacology (Q3)"
336;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.508;Q3;21;52;133;1475;175;132;1.12;28,37;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
337;4700152612;Current Nanoscience;journal;15734137;0.505;Q2;37;127;357;4915;621;349;1.71;38,70;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3)"
338;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.503;Q2;26;29;128;677;170;110;1.50;23,34;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
339;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.502;Q3;44;105;345;3169;540;291;1.95;30,18;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
340;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.501;Q2;36;11;74;158;99;69;1.46;14,36;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Cancer Research (Q3); Pharmacology (Q3)"
341;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.495;Q3;37;26;76;2332;110;70;1.15;89,69;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
342;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.493;Q3;22;19;52;910;49;51;1.06;47,89;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
343;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.493;Q2;53;216;598;7772;1014;593;1.71;35,98;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
344;19398;Acta Pharmaceutica;journal;13300075;0.49200000000000005;Q2;49;40;120;1332;238;120;1.51;33,30;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
345;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.491;Q3;55;122;344;3517;462;317;1.30;28,83;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
346;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0.488;Q2;37;1093;1991;29240;2205;1988;0.98;26,75;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
347;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.48100000000000004;Q3;7;2;12;279;22;11;0.33;139,50;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Biochemistry (Q3); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
348;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.478;Q1;43;57;71;2370;144;69;1.87;41,58;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
349;25864;Heterocycles;journal;03855414;0.47700000000000004;Q3;61;153;963;5437;990;959;1.00;35,54;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
350;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.473;Q3;52;132;303;5274;518;298;1.78;39,95;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
351;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.47100000000000003;Q3;42;58;125;2516;267;123;2.15;43,38;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
352;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.46799999999999997;Q1;45;134;377;4480;648;368;1.73;33,43;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
353;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.46399999999999997;Q3;62;72;180;3206;339;176;1.70;44,53;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
354;19700188360;Pharmaceutics;journal;19994923;0.46399999999999997;Q2;32;37;112;2142;184;112;1.81;57,89;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science (Q2)
355;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.46299999999999997;Q2;25;22;59;1821;106;55;1.97;82,77;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
356;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.45299999999999996;Q3;26;22;62;1225;85;55;1.71;55,68;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
357;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.452;Q2;50;158;232;4510;328;228;1.42;28,54;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
358;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.451;Q3;23;33;93;1706;153;88;1.74;51,70;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
359;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.45;Q2;35;187;302;5485;502;302;1.45;29,33;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
360;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.44799999999999995;Q3;33;33;89;1347;159;87;1.68;40,82;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
361;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.445;Q1;17;57;168;1252;173;168;0.91;21,96;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
362;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.445;Q3;58;108;379;1916;366;347;0.93;17,74;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
363;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.444;Q3;27;24;73;2171;145;69;2.21;90,46;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
364;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.44299999999999995;Q1;79;152;533;4901;741;521;1.32;32,24;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Cell Biology (Q4); Physiology (Q4)"
365;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.44299999999999995;Q2;53;88;200;3017;344;199;1.73;34,28;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
366;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.442;Q2;35;171;504;3457;618;503;1.16;20,22;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
367;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.44;Q2;37;95;138;3520;183;120;1.53;37,05;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
368;20580;Journal of Food Biochemistry;journal;01458884;0.436;Q3;40;87;333;2957;384;327;1.04;33,99;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
369;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.433;Q2;19;15;29;519;56;27;2.16;34,60;United States;Springer Science + Business Media;2010-ongoing;"Biomedical Engineering (Q2); Pharmaceutical Science (Q2); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
370;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.43200000000000005;Q3;62;139;400;2873;522;370;1.40;20,67;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
371;19300156901;Dose-Response;journal;15593258;0.429;Q3;30;41;129;1803;239;125;1.46;43,98;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
372;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.428;Q2;34;75;190;2268;357;188;1.52;30,24;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
373;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.424;Q3;20;23;74;2456;123;72;2.42;106,78;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical) (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3)"
374;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.42200000000000004;Q2;33;55;211;1313;159;178;0.93;23,87;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
375;27210;In Vivo;journal;0258851X;0.42100000000000004;Q3;54;132;450;3725;587;441;1.32;28,22;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
376;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.419;Q3;25;56;162;1994;195;160;1.21;35,61;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
377;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.41700000000000004;Q3;42;96;375;3689;521;355;1.42;38,43;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
378;17700155034;Natural product communications;journal;15559475, 1934578X;0.41200000000000003;Q3;35;449;1275;11023;1484;1250;1.11;24,55;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
379;21256;Drugs of Today;journal;16993993, 16994019;0.41100000000000003;Q3;46;69;244;2615;338;236;1.62;37,90;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
380;18800156720;Dissolution Technologies;journal;1521298X;0.41;Q2;28;35;87;419;80;83;1.09;11,97;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
381;22205;Saudi Pharmaceutical Journal;journal;13190164;0.41;Q2;36;53;114;1674;205;114;1.60;31,58;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
382;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.408;Q2;47;0;1302;0;1880;1302;1.25;0,00;Nigeria;Academic Journals;2009-2011;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
383;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.40700000000000003;Q1;52;249;710;3694;796;614;1.14;14,84;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
384;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.406;Q3;38;61;187;2844;250;186;1.23;46,62;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
385;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.40399999999999997;Q3;23;79;213;4372;152;210;0.76;55,34;United States;Current Medicine Group;2007-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
386;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;0.40399999999999997;Q1;22;45;187;810;216;170;0.95;18,00;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
387;21100318814;Pharmaceutical patent analyst;journal;20468962;0.40299999999999997;Q2;13;33;42;441;27;29;0.93;13,36;United Kingdom;Future Science;2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3)"
388;19700201140;Systematic Reviews in Pharmacy;journal;09758453;0.39899999999999997;Q2;11;7;38;455;43;37;0.35;65,00;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
389;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.395;Q3;45;134;551;3480;1015;529;1.91;25,97;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
390;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.39299999999999996;Q1;37;125;504;4457;571;493;1.17;35,66;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
391;4500151530;Personalized Medicine;journal;17410541;0.392;Q3;24;94;274;3420;280;214;1.19;36,38;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Molecular Medicine (Q4)"
392;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.39;Q1;32;31;65;1189;103;58;1.77;38,35;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
393;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.389;Q3;34;35;92;975;131;91;1.59;27,86;France;Springer Paris;1976-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
394;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.386;Q3;26;97;209;1772;201;110;1.62;18,27;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
395;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.385;Q3;29;58;333;2518;433;330;1.33;43,41;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q3)
396;21100205919;Open Drug Discovery Journal;journal;18773818;0.384;Q3;8;0;26;0;31;23;0.00;0,00;United Arab Emirates;Bentham Science Publishers;2010, 2014;Drug Discovery (Q3)
397;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.376;Q2;13;13;45;505;67;34;0.81;38,85;United States;IPEC-Americas;2010-ongoing;"Food Science (Q2); Pharmaceutical Science (Q2)"
398;22456;International Journal of Pharmacy Practice;journal;09617671;0.374;Q2;32;59;247;1513;206;224;1.20;25,64;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
399;19600162009;Advances in Molecular Toxicology;book series;18720854;0.371;Q3;10;7;23;939;31;20;1.31;134,14;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
400;19700174969;Archives of Drug Information;journal;17535174;0.368;Q1;10;0;11;0;19;11;3.00;0,00;United States;John Wiley & Sons Inc.;2008-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Complementary and Alternative Medicine (Q2); Pharmacology (medical) (Q3)"
401;21717;Die Pharmazie;journal;00317144;0.368;Q2;56;164;522;4991;650;522;1.22;30,43;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
402;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0.36700000000000005;Q2;29;162;294;3311;314;293;0.93;20,44;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
403;19700175099;Topics in Medicinal Chemistry;book series;18622461;0.366;Q3;8;0;32;0;18;24;1.23;0,00;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
404;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.365;Q2;21;73;106;1729;134;106;1.26;23,68;China;Xi'an Jiaotong University;2014-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Electrochemistry (Q3); Spectroscopy (Q3)"
405;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.363;Q2;55;48;119;1329;281;117;2.51;27,69;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Electrical and Electronic Engineering (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Computer Science Applications (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
406;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0.361;Q2;40;227;951;4933;866;951;0.75;21,73;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
407;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.36;Q3;52;174;516;2858;535;410;1.24;16,43;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
408;19400158813;HIV Therapy;journal;17584329, 17584310;0.359;Q3;12;0;48;0;32;37;0.00;0,00;United Kingdom;Future Medicine Ltd.;2009-2010;"Dermatology (Q3); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q3)"
409;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.359;Q1;12;11;49;287;35;34;1.21;26,09;United Kingdom;BioMed Central;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Health Policy (Q3)"
410;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.358;Q2;35;130;413;3519;502;408;0.99;27,07;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
411;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.358;Q3;18;15;53;380;46;47;1.26;25,33;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
412;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.355;Q2;38;78;192;4278;176;183;0.91;54,85;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
413;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.354;Q2;31;168;319;4898;307;307;0.93;29,15;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
414;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0.354;Q2;29;925;1162;18260;1118;1162;0.96;19,74;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q2)
415;130089;Toxin Reviews;journal;15569543, 15569551;0.353;Q3;38;10;32;647;46;30;0.89;64,70;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
416;4700152603;Medicinal Chemistry;journal;15734064;0.35;Q3;39;118;268;3731;349;260;1.34;31,62;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
417;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.35;Q3;25;24;81;1551;101;77;1.62;64,63;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
418;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.35;Q2;20;34;59;1060;98;59;1.47;31,18;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
419;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.34700000000000003;Q3;25;74;187;1748;216;180;1.12;23,62;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
420;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.34700000000000003;Q3;18;25;58;765;85;57;1.67;30,60;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy (Q3); Pharmacology (Q3)"
421;29947;Journal of Chemotherapy;journal;1120009X;0.34700000000000003;Q3;45;56;242;1951;245;206;1.29;34,84;United Kingdom;Maney Publishing;1989-ongoing;"Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
422;18384;Medicinal Chemistry Research;journal;10542523;0.342;Q2;38;604;808;19228;1214;804;1.49;31,83;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
423;19700201201;EPMA Journal;journal;18785077, 18785085;0.341;Q3;26;8;120;745;147;108;1.50;93,13;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical) (Q3); Drug Discovery (Q3); Health Policy (Q3)"
424;19700188318;International Journal of Advances in Pharmaceutical Sciences;journal;09761055;0.341;Q2;10;0;57;0;79;57;1.50;0,00;United States;Advanced Research Journals;2010-2011 (cancelled);"Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q3)"
425;11200153563;Drug Metabolism Letters;journal;18723128;0.34;Q2;23;26;101;697;128;100;1.22;26,81;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
426;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.34;Q3;40;163;460;4615;476;455;0.88;28,31;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
427;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.33799999999999997;Q3;33;78;206;2079;287;194;1.44;26,65;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
428;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.337;Q2;9;9;21;292;17;21;0.81;32,44;India;International Journal of Applied Pharmaceutics;2011-ongoing;Pharmaceutical Science (Q2)
429;130031;Journal of Toxicologic Pathology;journal;09149198;0.337;Q3;20;59;104;1569;94;104;1.06;26,59;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
430;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.335;Q3;58;38;126;1146;108;105;0.84;30,16;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
431;15600154705;EnvironmentAsia;journal;19061714;0.33399999999999996;Q3;14;23;103;552;74;103;0.69;24,00;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q2); Toxicology (Q3)"
432;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.33299999999999996;Q3;8;17;35;1160;25;34;1.12;68,24;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
433;19900192163;Results in Pharma Sciences;journal;22112863;0.331;Q2;13;3;24;107;25;24;1.04;35,67;Netherlands;Elsevier BV;2011-ongoing;Pharmaceutical Science (Q2)
434;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0.33;Q3;2;1;2;18;4;2;2.00;18,00;India;Open Access Science Research Publisher;2013;"Drug Discovery (Q3); Plant Science (Q3)"
435;19700175040;Open Vaccine Journal;journal;18750354;0.33;Q2;9;3;31;170;15;29;0.67;56,67;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Immunology (Q4)"
436;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.32799999999999996;Q2;25;181;538;2550;328;340;1.33;14,09;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
437;21192;Drug Development Research;journal;02724391, 10982299;0.327;Q3;54;67;208;3437;201;202;0.83;51,30;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
438;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.327;Q2;27;109;226;2210;267;187;1.43;20,28;India;Medknow Publications and Media Pvt. Ltd;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
439;19700181240;Global Journal of Pharmacology;journal;19920075;0.326;Q2;13;39;75;1171;136;75;2.25;30,03;Pakistan;International Digital Organization for Scientific Information (IDOSI);2010-2014 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
440;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.325;Q3;27;103;225;3101;249;225;1.10;30,11;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
441;19383;Fluoride - Quarterly Reports;journal;00154725;0.32299999999999995;Q3;41;34;117;866;119;107;1.28;25,47;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Biochemistry (Q3); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
442;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.32299999999999995;Q2;50;117;393;2942;418;390;0.63;25,15;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
443;22357;IDrugs : the investigational drugs journal;journal;13697056;0.322;Q3;32;0;178;0;177;176;0.00;0,00;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
444;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.322;Q3;41;113;375;4250;312;369;1.00;37,61;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
445;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.317;Q2;43;110;391;3126;325;390;0.69;28,42;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
446;21100218055;BMC pharmacology & toxicology;journal;20506511;0.312;Q3;23;62;21;1946;17;18;0.94;31,39;United Kingdom;BioMed Central;2012-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
447;21810;Farmacia;journal;00148237;0.308;Q2;19;141;276;2813;402;274;1.54;19,95;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
448;21100196907;Open Toxinology Journal;journal;18754147;0.306;Q3;2;1;1;55;2;1;2.00;55,00;United Arab Emirates;Bentham Science Publishers;2011-2013;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
449;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.302;Q3;30;44;119;1394;122;116;0.80;31,68;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
450;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.299;Q2;25;0;535;0;528;535;0.91;0,00;Nigeria;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
451;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.299;Q3;43;31;98;1366;104;98;1.15;44,06;United States;Begell House;1984-1990, 1992-ongoing;"Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
452;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.295;Q3;19;49;153;903;107;115;0.63;18,43;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
453;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.294;Q2;22;44;108;1755;118;107;0.82;39,89;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
454;130038;Letters in Drug Design and Discovery;journal;15701808;0.294;Q2;28;131;377;3537;412;372;0.99;27,00;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
455;19446;American Pharmaceutical Review;journal;10998012;0.293;Q2;20;65;246;1049;135;232;0.55;16,14;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q2)
456;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.29;Q2;26;24;69;957;110;68;1.77;39,88;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
457;5800173401;Current Bioactive Compounds;journal;15734072;0.28800000000000003;Q2;21;27;98;1793;71;86;0.71;66,41;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
458;144963;Drug Discovery Today: Disease Models;journal;17406757;0.28800000000000003;Q3;23;33;76;1588;52;68;0.76;48,12;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
459;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.28800000000000003;Q2;46;222;557;5590;442;553;0.78;25,18;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
460;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.285;Q4;38;45;170;6173;144;162;0.46;137,18;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Cancer Research (Q4); Toxicology (Q4)"
461;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.282;Q3;30;7;42;217;21;39;0.67;31,00;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
462;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0.281;Q2;26;443;694;11489;446;691;0.57;25,93;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
463;19700180522;Molecular and Cellular Toxicology;journal;1738642X;0.281;Q2;18;52;154;1717;134;150;0.92;33,02;Germany;Springer Verlag;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
464;20578;Journal of Food and Drug Analysis;journal;10219498;0.28;Q3;41;89;269;2228;166;263;0.48;25,03;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
465;19700174961;BioProcess International;trade journal;15426319;0.275;Q3;20;104;490;841;197;464;0.44;8,09;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
466;144879;Toxicology International;journal;09716580;0.275;Q4;21;43;116;1173;128;112;0.98;27,28;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
467;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.272;Q3;26;70;211;2808;186;211;0.93;40,11;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Drug Discovery (Q3); Pharmacology (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
468;25144;Journal of Health Science;journal;13475207, 13449702;0.271;Q4;42;0;162;0;152;155;1.17;0,00;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
469;35190;Revista Espanola de Quimioterapia;journal;02143429;0.271;Q3;23;61;137;1352;95;104;0.96;22,16;Spain;Sociedad Española de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
470;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;0.27;Q2;5;30;59;159;15;47;0.37;5,30;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
471;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0.27;Q2;18;59;176;1799;109;171;0.41;30,49;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
472;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.267;Q2;15;31;112;855;38;96;0.26;27,58;United States;SAGE Publications Inc.;2000-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
473;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.264;Q2;35;68;154;1690;163;148;1.00;24,85;United States;Informa Healthcare;2013-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
474;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.264;Q4;55;85;219;1600;151;170;0.91;18,82;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medical Laboratory Technology (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
475;15500154707;International Journal of Biological Chemistry;journal;1819155X;0.264;Q3;12;8;61;296;69;59;1.15;37,00;Pakistan;ANSInet;2009-2016 (cancelled);"Pharmacology (Q3); Biochemistry (Q4)"
476;19700188355;International Journal of Phytomedicine;journal;09750185;0.263;Q3;15;75;190;2328;152;190;0.63;31,04;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
477;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.263;Q3;15;16;81;651;68;64;0.95;40,69;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
478;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.262;Q3;17;38;103;1871;108;80;1.62;49,24;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
479;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.26;Q3;18;249;790;5818;465;789;0.75;23,37;India;Scientific Publishers;2008-ongoing;"Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Biochemistry (Q4); Environmental Chemistry (Q4)"
480;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;0.259;Q2;19;23;114;836;105;114;0.92;36,35;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
481;19700175758;International Journal of Drug Development and Research;journal;09759344;0.259;Q2;17;196;465;5072;268;464;0.65;25,88;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
482;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.258;Q2;15;0;93;0;69;93;0.27;0,00;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q2)
483;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.258;Q2;28;384;733;10624;486;731;0.66;27,67;India;MediPoeia;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
484;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;0.257;Q3;18;32;52;1017;46;52;0.97;31,78;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery (Q3)
485;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.256;Q3;6;5;14;109;13;13;0.60;21,80;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
486;21100241608;Journal of Nanomedicine and Nanotechnology;journal;21577439;0.252;Q2;19;43;77;1819;59;53;1.12;42,30;India;OMICS Publishing Group;2010-2014 (cancelled);"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Bioengineering (Q4)"
487;19700174978;American Journal of Pharmacy Benefits;journal;19454481;0.25;Q2;11;54;166;1035;56;137;0.36;19,17;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Business and International Management (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Decision Sciences (miscellaneous) (Q3)"
488;19700200724;Der Pharmacia Lettre;journal;09755071;0.249;Q2;24;280;527;6997;291;527;0.55;24,99;United States;Scholars Research Library;2011-2016 (cancelled);Pharmaceutical Science (Q2)
489;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.249;Q2;14;31;87;1025;66;73;1.08;33,06;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q3); Neuroscience (miscellaneous) (Q4)"
490;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.248;Q4;26;72;167;2815;159;161;0.99;39,10;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
491;73430;Pharmaceutical Technology;journal;15432521;0.248;Q2;35;157;630;612;92;544;0.16;3,90;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q4)"
492;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.24600000000000002;Q3;33;29;40;3674;25;37;0.68;126,69;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
493;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.245;Q3;19;62;92;1570;74;92;0.79;25,32;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q3)
494;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.243;Q2;32;103;275;3785;166;263;0.48;36,75;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
495;21100238633;BioImpacts;journal;22285652, 22285660;0.24100000000000002;Q3;24;31;63;1101;62;58;1.07;35,52;Iran;Tabriz University of Medical Sciences;2011-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
496;21811;Farmacia Hospitalaria;journal;11306343;0.24100000000000002;Q3;21;95;286;2175;151;176;0.85;22,89;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
497;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;0.24100000000000002;Q2;9;10;48;287;27;48;0.60;28,70;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science (Q2)
498;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.239;Q3;47;0;86;0;72;77;0.00;0,00;Spain;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
499;19700175096;Pharmacognosy Journal;journal;09753575;0.23800000000000002;Q3;14;54;365;1281;134;362;0.33;23,72;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
500;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.23600000000000002;Q3;16;63;189;2289;118;169;0.60;36,33;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
501;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.23600000000000002;Q3;17;16;51;633;33;51;0.71;39,56;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
502;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.23600000000000002;Q2;10;27;72;956;46;72;0.40;35,41;Turkey;Marmara University;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
503;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.23600000000000002;Q3;23;82;245;2866;116;241;0.31;34,95;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
504;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0.235;Q2;16;25;123;597;66;117;0.34;23,88;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
505;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;0.235;Q3;24;544;977;15869;541;973;0.36;29,17;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science (Q3)
506;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.235;Q3;27;150;190;5328;174;187;0.86;35,52;Iran;University of Medical Sciences;2010-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Biophysics (Q4); Clinical Biochemistry (Q4); Immunology and Microbiology (miscellaneous)  (Q4)"
507;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.23399999999999999;Q3;45;63;173;1462;108;147;0.51;23,21;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
508;17700156303;Neuromethods;book series;19406045, 08932336;0.23399999999999999;Q2;17;145;477;9977;161;427;0.40;68,81;United States;Humana Press, Inc.;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
509;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.233;Q2;9;14;37;466;24;34;0.31;33,29;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
510;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.231;Q3;22;49;132;1467;104;115;0.94;29,94;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
511;4700152607;Current Enzyme Inhibition;journal;15734080;0.231;Q3;15;18;60;1416;41;55;0.56;78,67;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
512;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.231;Q3;11;42;85;1194;44;85;0.53;28,43;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
513;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.231;Q2;29;272;773;7039;516;773;0.68;25,88;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
514;19700188326;American Journal of Drug Discovery and Development;journal;2150427X, 21504296;0.22899999999999998;Q3;9;33;34;906;35;34;1.03;27,45;United States;Academic Journals Inc.;2011-2016 (cancelled);Drug Discovery (Q3)
515;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0.22899999999999998;Q3;27;19;102;750;62;102;0.47;39,47;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
516;21100470510;Drug Research;journal;21949379, 21949387;0.226;Q3;56;142;384;3012;275;373;0.65;21,21;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
517;19700201333;International Journal of Drug Delivery;journal;09750215;0.225;Q3;11;46;95;1461;47;95;0.49;31,76;United States;Advanced Research Journals;2011-2016 (cancelled);Pharmaceutical Science (Q3)
518;21100258853;F1000Research;journal;20461402;0.22399999999999998;Q2;32;208;47;7295;20;43;0.47;35,07;United Kingdom;F1000 Research Ltd.;2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4)"
519;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;0.22399999999999998;Q2;15;100;243;2367;141;243;0.26;23,67;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
520;21100301603;National Journal of Physiology, Pharmacy and Pharmacology;journal;23204672;0.22399999999999998;Q2;7;35;44;725;53;39;1.36;20,71;India;Mrs Dipika Charan for MedScience Publishers;2011-2017 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Physiology (Q4)"
521;23489;Chemical Speciation and Bioavailability;journal;09542299;0.218;Q4;25;35;91;1353;41;91;0.43;38,66;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
522;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.218;Q3;30;42;84;1771;61;83;0.38;42,17;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
523;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.217;Q2;15;12;112;333;75;112;0.68;27,75;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
524;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.213;Q3;7;0;32;0;31;32;0.56;0,00;United Kingdom;Inderscience Publishers;2010-2012;"Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
525;21100451405;Natural Products Journal;journal;22103163, 22103155;0.213;Q4;9;30;67;1281;29;63;0.46;42,70;Netherlands;Bentham Science Publishers B.V.;2011-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
526;21100219314;Applied and Translational Genomics;journal;22120661;0.212;Q3;13;13;8;912;3;7;0.43;70,15;Netherlands;Elsevier BV;2012-ongoing;"Biotechnology (Q3); Pharmaceutical Science (Q3); Molecular Biology (Q4)"
527;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.212;Q4;18;119;379;1862;26;379;0.06;15,65;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
528;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.212;Q3;24;35;89;1025;42;87;0.50;29,29;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
529;5800179590;Pharmacologyonline;journal;18278620;0.21;Q3;21;74;759;2031;271;758;0.40;27,45;Italy;SILAE;2007-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
530;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.20800000000000002;Q3;19;32;106;890;59;103;0.43;27,81;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
531;19500156813;Procedia in Vaccinology;journal;1877282X;0.20800000000000002;Q3;10;0;99;0;52;98;0.39;0,00;Netherlands;Elsevier BV;2009-2012;"Infectious Diseases (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
532;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0.20800000000000002;Q4;12;32;113;1110;49;112;0.52;34,69;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
533;21795;Farmaceuticky Obzor;journal;00148172;0.207;Q3;7;18;100;399;14;92;0.15;22,17;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
534;19700175049;Internet Journal of Toxicology;journal;15593916;0.207;Q4;5;6;24;106;17;24;0.00;17,67;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
535;19700188309;Journal of Bioanalysis and Biomedicine;journal;1948593X;0.207;Q3;9;38;65;1387;33;58;0.71;36,50;India;OMICS Publishing Group;2010-2014 (cancelled);Pharmaceutical Science (Q3)
536;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.207;Q2;18;60;346;1042;155;345;0.33;17,37;India;Rasayan Journal;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
537;21265;Drugs of the Future;journal;03778282;0.205;Q3;40;114;337;3797;159;330;0.36;33,31;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
538;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.204;Q3;23;80;54;2079;48;54;0.89;25,99;Iran;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
539;145693;Canadian Pharmacists Journal;journal;17151635;0.204;Q3;18;100;328;719;66;142;0.42;7,19;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
540;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.204;Q3;15;45;119;893;24;114;0.23;19,84;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
541;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;0.204;Q3;6;0;19;0;13;10;1.30;0,00;India;Medknow Publications;2011;Pharmaceutical Science (Q3)
542;79053;Natural Product Sciences;journal;12263907;0.204;Q4;22;52;161;1559;64;161;0.42;29,98;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
543;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.201;Q3;21;0;0;0;0;0;0.00;0,00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
544;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.2;Q3;21;14;46;686;32;44;0.67;49,00;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
545;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.2;Q4;12;27;75;720;33;68;0.49;26,67;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q4); Drug Discovery (Q4)"
546;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.19899999999999998;Q3;14;92;127;1879;47;112;0.37;20,42;Netherlands;Elsevier BV;2009-ongoing;"Pharmacy (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
547;19700170617;EXCLI Journal;journal;16112156;0.19899999999999998;Q3;24;95;145;3855;117;124;0.95;40,58;Germany;University of Mainz;2009-ongoing;"Pharmacology (Q3); Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
548;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0.19899999999999998;Q3;9;35;155;1194;53;154;0.32;34,11;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q3); Physiology (Q4)"
549;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.19899999999999998;Q3;15;12;33;1144;19;21;0.67;95,33;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
550;22854;Yakugaku Zasshi;journal;00316903;0.19899999999999998;Q3;37;177;533;4064;255;480;0.43;22,96;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
551;21100244805;Journal of Vaccines and Vaccination;journal;21577560;0.19699999999999998;Q4;9;60;78;2185;32;64;0.46;36,42;India;OMICS Publishing Group;2010-2014 (cancelled);"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
552;20400195018;International Journal of Pharmacognosy and Phytochemical Research;journal;09754873;0.196;Q4;14;61;59;1285;24;59;0.41;21,07;India;International Journal of Pharmacognosy and Phytochemical Research;2011-2016 (cancelled);Drug Discovery (Q4)
553;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;0.195;Q3;10;29;15;2580;5;14;0.00;88,97;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
554;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.19399999999999998;Q3;10;78;156;2383;67;156;0.43;30,55;China;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-ongoing;Pharmaceutical Science (Q3)
555;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.193;Q3;16;46;22;973;15;18;0.83;21,15;United States;Wiley-Blackwell;2012-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
556;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.193;Q3;16;47;48;1809;27;48;0.56;38,49;Netherlands;Springer Netherlands;2012-ongoing;"Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
557;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.193;Q3;17;241;670;1834;45;656;0.08;7,61;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
558;19900192173;International Journal of Pharmaceutical and Clinical Research;journal;09751556;0.192;Q3;9;28;35;830;9;35;0.26;29,64;Australia;International Journal of Pharmaceutical and Clinical Research;2011-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
559;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.191;Q3;16;29;59;1104;31;59;0.35;38,07;United States;Science Publications;2007-2016 (cancelled);"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
560;23171;Korean Journal of Pharmacognosy;journal;02533073;0.191;Q3;14;46;102;1132;37;102;0.46;24,61;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
561;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.19;Q3;12;36;100;1027;53;89;0.59;28,53;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
562;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;0.19;Q3;24;682;1319;15761;479;1319;0.29;23,11;India;RJPBCS;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
563;19700175149;African Journal Biomedical Research;journal;11195096;0.18899999999999997;Q3;15;23;105;599;42;104;0.35;26,04;Nigeria;Bioline International;2008, 2010-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
564;58808;Pharmaceutical Care and Research;journal;16712838;0.18899999999999997;Q3;7;159;470;1361;38;468;0.09;8,56;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
565;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q3;5;156;412;703;7;372;0.02;4,51;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
566;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0.187;Q3;20;61;317;1569;156;317;0.34;25,72;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q3)
567;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.18600000000000003;Q3;4;17;126;348;18;113;0.19;20,47;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
568;19700170837;Vitae;journal;01214004;0.182;Q3;11;73;88;814;38;79;0.43;11,15;Colombia;Universidad de Antioquia;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
569;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.18100000000000002;Q3;14;27;85;1397;35;79;0.50;51,74;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
570;20065;BioPharm International;journal;1542166X;0.18;Q3;25;130;358;421;82;328;0.20;3,24;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
571;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.18;Q4;22;12;211;500;116;188;0.48;41,67;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q4); Infectious Diseases (Q4); Parasitology (Q4); Toxicology (Q4)"
572;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.179;Q3;10;29;72;466;27;72;0.31;16,07;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
573;21758;Prescrire International;journal;11677422;0.179;Q3;11;220;595;1038;103;547;0.21;4,72;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
574;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.17800000000000002;Q4;9;44;159;952;18;159;0.08;21,64;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
575;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.17800000000000002;Q4;34;32;74;786;29;68;0.49;24,56;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
576;80593;Journal of Medicinal Plants;journal;16840240;0.17800000000000002;Q3;16;52;234;1755;101;234;0.42;33,75;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
577;21100469670;Antibiotics;journal;20796382;0.17600000000000002;Q3;20;32;6;2220;3;5;0.75;69,38;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Infectious Diseases (Q4); Microbiology (Q4); Microbiology (medical) (Q4)"
578;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.17600000000000002;Q3;8;5;140;67;54;140;0.38;13,40;India;R R College of Pharmacy;2010, 2012-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
579;19700188484;Journal of Bioequivalence and Bioavailability;journal;09750851;0.17600000000000002;Q3;10;55;93;1154;32;78;0.41;20,98;India;OMICS Publishing Group;2011-2014 (cancelled);Pharmaceutical Science (Q3)
580;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0.17300000000000001;Q3;11;92;105;1117;45;104;0.21;12,14;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
581;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.172;Q3;5;4;3;123;4;3;0.00;30,75;United Arab Emirates;Bentham Science Publishers;2009-2010, 2013;"Pharmaceutical Science (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
582;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.172;Q3;8;53;165;987;21;153;0.12;18,62;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q4)"
583;22934;Chinese Pharmaceutical Journal;journal;10012494;0.17;Q3;19;475;1451;7730;331;1450;0.23;16,27;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
584;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.17;Q3;9;14;103;511;10;94;0.14;36,50;Netherlands;IOS Press;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
585;22908;Chinese Pharmacological Bulletin;journal;10011978;0.16899999999999998;Q4;15;420;1281;6807;460;1281;0.38;16,21;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q4)
586;21083;Pharmaceutical Care Espana;journal;11396202;0.16899999999999998;Q3;9;29;85;328;12;60;0.22;11,31;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
587;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.16899999999999998;Q4;11;63;121;1548;36;116;0.35;24,57;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
588;19700174925;European Pharmaceutical Review;trade journal;13608606;0.166;Q3;7;64;122;986;23;120;0.27;15,41;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
589;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.166;Q3;26;863;2267;14947;724;2266;0.29;17,32;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
590;21100265336;International Arabic Journal of Antimicrobial Agents;journal;21749094;0.165;Q4;6;16;24;461;10;23;0.43;28,81;United Kingdom;Internet Medical Publishing;2011-2015;"Pharmacology (medical) (Q3); Microbiology (medical) (Q4); Pharmacology (Q4)"
591;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.16399999999999998;Q4;9;29;54;723;18;54;0.37;24,93;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
592;19700200708;Journal of Global Pharma Technology;journal;09758542;0.163;Q3;10;12;219;292;66;212;0.19;24,33;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science (Q3)
593;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.163;Q4;5;0;11;0;3;11;0.10;0,00;United Arab Emirates;Bentham Science Publishers;2009-2012;"Pharmacology (medical) (Q3); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
594;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0.162;Q4;12;5;93;133;62;93;0.85;26,60;United States;Academic Journals Inc.;2009-2016 (cancelled);"Pollution (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
595;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.162;Q4;8;13;17;891;3;15;0.20;68,54;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
596;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.161;Q3;6;0;18;0;9;18;0.33;0,00;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
597;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0.161;Q3;7;0;57;0;26;52;0.38;0,00;India;Medknow Publications;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
598;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.161;Q4;26;141;458;2665;138;409;0.31;18,90;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
599;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.161;Q3;5;15;44;481;5;37;0.04;32,07;Switzerland;Springer International Publishing AG;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
600;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.16;Q4;19;29;108;2027;51;97;0.57;69,90;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
601;110097;Food and Drug Law Journal;journal;1064590X;0.16;Q4;18;21;83;370;37;81;0.40;17,62;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
602;21100301409;Issues in Toxicology;book series;17577179;0.16;Q4;12;40;122;8309;45;114;0.26;207,73;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
603;144613;Journal of Generic Medicines;journal;17411343;0.16;Q3;14;33;105;506;30;91;0.30;15,33;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
604;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.16;Q3;9;32;89;189;4;87;0.05;5,91;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
605;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0.159;Q3;10;47;150;1573;58;150;0.36;33,47;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
606;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.159;Q3;8;22;65;595;18;65;0.27;27,05;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q3)
607;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.159;Q4;16;20;73;546;18;73;0.31;27,30;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
608;130170;Phytotherapie;journal;17652847, 16248597;0.159;Q4;12;90;203;1704;36;159;0.18;18,93;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
609;21100202909;Drug Invention Today;journal;09757619;0.157;Q4;12;55;90;1294;25;90;0.28;23,53;India;Association of Pharmaceutical Innovators;2012-ongoing;Drug Discovery (Q4)
610;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.157;Q4;22;0;36;0;22;36;0.87;0,00;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q4)
611;19700177006;Psychopharm Review;trade journal;19369255;0.157;Q4;4;12;36;483;16;36;0.38;40,25;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology (medical) (Q3); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
612;19700200880;Botulinum Journal;journal;17547326;0.156;Q3;5;4;25;70;9;24;0.50;17,50;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
613;73076;Drug Discovery World;journal;14694344;0.156;Q4;10;44;140;473;23;124;0.14;10,75;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
614;21800;Farmacevtski Vestnik;journal;00148229;0.156;Q3;4;55;154;1034;14;138;0.07;18,80;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q4)"
615;5200152843;Farmaceutico Hospitales;journal;02144697;0.155;Q3;3;0;35;0;3;22;0.23;0,00;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
616;13718;Pharmaceutical Engineering;journal;02738139;0.154;Q3;13;55;160;419;22;143;0.15;7,62;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
617;15340;Developments in Biologicals;book series;14246074;0.153;Q4;35;22;21;543;7;21;0.35;24,68;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Biomaterials (Q4); Immunology (Q4); Pharmacology (Q4)"
618;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;0.153;Q3;7;0;26;0;9;26;0.35;0,00;Bangladesh;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science (Q3)
619;19900192735;International Drug Discovery;journal;21504806, 21504792;0.152;Q4;4;0;32;0;11;32;0.34;0,00;United States;Russell Publishing LLC;2011-2012;Drug Discovery (Q4)
620;24097;Journal of the Indian Chemical Society;journal;00194522;0.15;Q4;31;292;685;8354;184;677;0.23;28,61;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
621;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.15;Q3;14;264;691;6015;97;691;0.14;22,78;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
622;19700201404;Open Drug Safety Journal;journal;18768180;0.149;Q3;3;2;10;54;1;10;0.11;27,00;Netherlands;Bentham Science Publishers B.V.;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
623;15842;Journal of Applied Research;journal;1537064X;0.14800000000000002;Q4;18;2;40;203;14;39;0.17;101,50;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
624;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.14800000000000002;Q3;5;12;41;309;6;34;0.14;25,75;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
625;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.14800000000000002;Q3;7;7;50;111;16;50;0.25;15,86;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
626;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.147;Q4;9;40;127;939;31;117;0.20;23,48;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
627;21100431352;Proceedings of ISMA 2010 - International Conference on Noise and Vibration Engineering, including USD 2010;conference and proceedings;00002010;0.147;-;12;0;387;0;85;386;0.00;0,00;Belgium;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
628;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.146;Q3;7;10;50;279;13;49;0.29;27,90;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
629;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.146;Q4;7;102;401;2041;41;401;0.09;20,01;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
630;19700201471;International Journal of Pharmacy and Technology;journal;0975766X;0.146;Q3;15;105;389;2491;106;388;0.27;23,72;India;International Journal of Pharmacy and Technology(IJPT);2011-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
631;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.146;Q3;15;35;41;842;16;37;0.43;24,06;Netherlands;Kowsar Publishing Company;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
632;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.146;Q4;5;32;54;633;12;48;0.25;19,78;Italy;Elsevier Masson SAS;2014-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
633;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.14400000000000002;Q4;18;106;436;449;89;339;0.24;4,24;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
634;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.14300000000000002;Q4;36;147;252;63;344;247;1.11;0,43;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
635;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.14300000000000002;Q3;9;24;89;566;31;89;0.25;23,58;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
636;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.14300000000000002;Q4;8;41;128;1059;35;128;0.19;25,83;Netherlands;IOS Press;2010-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
637;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.14300000000000002;Q3;12;66;43;1790;27;39;0.69;27,12;United States;Elsevier USA;2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Economics, Econometrics and Finance (miscellaneous) (Q4); Health Policy (Q4)"
638;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.142;Q3;13;661;1400;11811;278;1298;0.19;17,87;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
639;17600155051;Drug Delivery Technology;trade journal;15372898;0.142;Q3;9;78;268;356;37;185;0.15;4,56;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q3)
640;22375;Indian Drugs;journal;0019462X;0.142;Q3;30;84;322;2049;47;322;0.11;24,39;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
641;19700174997;ONdrugDelivery;trade journal;2049145X;0.142;Q3;5;47;129;188;11;110;0.08;4,00;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q3)
642;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.142;Q3;8;39;93;1168;12;81;0.16;29,95;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
643;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.141;Q4;18;16;39;435;14;39;0.42;27,19;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
644;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.141;Q4;14;80;158;2445;29;158;0.14;30,56;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q4)
645;9800153137;Trastornos Adictivos;journal;15750973;0.141;Q4;8;0;69;0;14;54;0.24;0,00;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
646;22906;Journal of China Pharmaceutical University;journal;10005048;0.14;Q4;13;91;323;1688;57;323;0.14;18,55;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
647;21716;Pharmazeutische Zeitung;journal;00317136;0.14;Q4;7;752;1617;641;13;996;0.01;0,85;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
648;21412;Zeitschrift für Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.14;Q4;12;58;182;787;15;131;0.11;13,57;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
649;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.139;Q4;14;9;44;200;16;38;0.18;22,22;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
650;19700174645;Journal of International Pharmaceutical Research;journal;16740440;0.139;Q3;8;46;214;1137;57;208;0.17;24,72;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmaceutical Science (Q4)"
651;19700175061;Open Pharmacology Journal;journal;18741436;0.139;Q4;6;4;10;130;6;10;0.33;32,50;United Arab Emirates;Bentham Science Publishers;2009-2013;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
652;21100223537;European Journal of Hospital Pharmacy: Science and Practice;journal;20479956, 20479964;0.13699999999999998;Q3;11;104;139;1228;22;64;0.34;11,81;Belgium;European Association of Hospital Pharmacists (EAHP);2012-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
653;19500157008;Fooyin Journal of Health Sciences;journal;18778607;0.13699999999999998;Q4;5;0;21;0;9;20;0.00;0,00;Netherlands;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
654;4700152769;Pharmacopeial Forum;journal;03634655;0.13699999999999998;Q4;16;27;55;276;16;32;0.24;10,22;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Drug Guides (Q3); Pharmacy (Q3); Pharmacology (Q4)"
655;19200156925;Cancer Therapy;journal;15439143, 15439135;0.136;Q4;8;9;23;419;14;23;2.00;46,56;United States;Gene Therapy Press;2009-2014;"Cancer Research (Q4); Oncology (Q4); Pharmacology (Q4)"
656;19700172219;ISB 2010 Proceedings - International Symposium on Biocomputing;conference and proceedings;00002010;0.136;-;4;0;50;0;8;48;0.00;0,00;United States;;2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Computational Theory and Mathematics; Pharmaceutical Science; Software"
657;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.135;Q4;8;16;15;378;1;15;0.07;23,63;Italy;Scuola IaD;2015-ongoing;"Architecture (Q2); Media Technology (Q2); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4); Human-Computer Interaction (Q4); Pharmacology (Q4)"
658;19700175125;Internet Journal of Pharmacology;journal;15312976;0.135;Q4;7;0;30;0;6;30;0.00;0,00;United States;Internet Scientific Publications;2009-2011;Pharmacology (Q4)
659;5200152604;Pharma Times;journal;00316849;0.135;Q3;10;91;231;917;29;166;0.14;10,08;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
660;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;0.133;Q3;8;29;51;1118;20;51;0.39;38,55;Canada;Lifescience Global;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
661;21211;Pharmacy Education;journal;14772701, 15602214;0.133;Q4;15;20;68;370;10;68;0.13;18,50;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
662;21100804474;European Pharmaceutical Journal;journal;24536725;0.132;Q3;5;24;49;325;8;48;0.11;13,54;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
663;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.132;Q4;7;0;54;0;11;54;0.20;0,00;Australia;International Journal of Drug Delivery Technology;2011-ongoing;Pharmaceutical Science (Q4)
664;25253;Blutalkohol;journal;00065250;0.13;Q4;13;17;108;281;14;102;0.21;16,53;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
665;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254;0.13;Q4;5;0;53;0;17;52;0.33;0,00;Taiwan;Elsevier Taiwan;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
666;21100201952;Arsenic in Geosphere and Human Diseases, As 2010 - 3rd International Congress: Arsenic in the Environment;conference and proceedings;00002010;0.129;-;4;0;234;0;21;229;0.00;0,00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
667;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.129;Q4;7;1;3;166;2;3;0.50;166,00;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
668;22979;Journal of Applied Therapeutic Research;journal;10292659;0.128;Q4;7;0;25;0;5;25;0.06;0,00;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
669;21100197929;Toxicological Research;journal;19768257;0.128;Q4;20;72;91;2519;17;91;0.20;34,99;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
670;22977;Journal de Pharmacie de Belgique;journal;00472166;0.127;Q4;12;31;93;528;10;88;0.07;17,03;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
671;19700174658;Regulatory Rapporteur;trade journal;17428955;0.127;Q3;5;78;212;489;14;164;0.09;6,27;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacy (Q3)"
672;5800173394;Current Drug Therapy;journal;15748855;0.126;Q4;14;21;107;1374;30;99;0.36;65,43;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
673;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.126;Q4;11;17;62;17;11;62;0.06;1,00;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
674;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.125;Q4;12;15;50;314;9;49;0.24;20,93;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
675;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.125;Q4;8;33;85;1108;13;65;0.12;33,58;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
676;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.124;Q4;10;46;125;920;25;108;0.18;20,00;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine (Q4); Critical Care and Intensive Care Medicine (Q4); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
677;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.124;Q4;18;24;239;525;23;237;0.26;21,88;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
678;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.124;Q4;3;0;21;0;8;19;0.18;0,00;New Zealand;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
679;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0.12300000000000001;Q4;3;29;107;983;2;105;0.03;33,90;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
680;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.12300000000000001;Q4;2;16;54;239;3;54;0.08;14,94;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
681;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.12300000000000001;Q4;11;156;346;3639;56;346;0.17;23,33;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
682;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;0.12300000000000001;Q4;8;11;40;219;11;40;0.21;19,91;Turkey;Moment Publications;2011-ongoing;"Analytical Chemistry (Q4); Electrochemistry (Q4); Pharmaceutical Science (Q4); Spectroscopy (Q4)"
683;21798;Farmaceutski Glasnik;journal;00148202;0.12300000000000001;Q4;5;77;202;462;4;164;0.03;6,00;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
684;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.12300000000000001;Q4;6;59;81;205;10;76;0.13;3,47;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
685;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;19430868, 1943085X;0.12300000000000001;Q4;11;0;99;0;34;98;0.34;0,00;United States;Taylor and Francis;2009-2012;"Biomedical Engineering (Q4); Nanoscience and Nanotechnology (Q4); Pharmaceutical Science (Q4)"
686;19700175137;Trends in Medical Research;journal;18193587;0.12300000000000001;Q4;8;6;25;192;8;25;0.35;32,00;United States;Academic Journals Inc.;2008-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
687;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.122;Q4;3;0;1;0;0;1;0.00;0,00;Netherlands;Bentham Science Publishers B.V.;2012, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
688;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.122;Q4;3;10;2;308;0;1;0.00;30,80;United Kingdom;Taylor and Francis Inc.;2011-2014;"Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4); Materials Science (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
689;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.122;Q4;1;0;1;0;0;1;0.00;0,00;India;IJLBPR Editorial Office;2012, 2014, 2016-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
690;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.122;Q4;1;0;1;0;0;1;0.00;0,00;India;International Journal of Pharma Medicine and Biological Sciences;2012, 2016-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
691;21100293201;International Journal of Research in Ayurveda and Pharmacy;journal;22774343, 22293566;0.122;Q4;8;203;194;3913;26;194;0.13;19,28;India;Moksha Publishing House;2012-2016 (cancelled);"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
692;21100465007;International Research Journal of Pharmacy;journal;22308407;0.122;Q4;0;0;0;0;0;0;0.00;0,00;India;Moksha Publishing House;2012, 2014-ongoing;Pharmaceutical Science (Q4)
693;19700201410;Milestones in Drug Therapy;book series;22966056;0.122;Q4;4;31;110;2911;15;106;0.15;93,90;United States;Springer Science + Business Media;2010-ongoing;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
694;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.122;Q4;12;20;82;591;15;82;0.23;29,55;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
695;13000154717;Current Topics in Toxicology;journal;09728228;0.121;Q4;6;1;21;30;6;21;0.29;30,00;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
696;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;0.121;Q4;13;0;6;0;3;6;0.33;0,00;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
697;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.12;Q4;7;6;18;254;4;18;0.00;42,33;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
698;21000195625;Asian Journal of Pharmaceutical Research and Health Care;journal;22501444, 22501460;0.12;Q4;4;13;26;259;3;19;0.16;19,92;India;Journal of Pharmaceutical Research and Health Care;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
699;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.12;Q4;13;96;247;1634;31;247;0.15;17,02;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
700;19800188037;2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010;conference and proceedings;00002010;0.11900000000000001;-;4;0;54;0;9;51;0.00;0,00;United States;;2010;"Molecular Medicine; Pharmacology"
701;19700174886;Arzneimitteltherapie;journal;07236913;0.11900000000000001;Q4;6;152;441;874;25;233;0.12;5,75;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
702;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.11900000000000001;Q4;13;123;374;1103;48;371;0.10;8,97;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
703;22514;Japanese Journal of Chemotherapy;journal;13407007;0.11900000000000001;Q4;12;22;96;386;10;96;0.06;17,55;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
704;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;0.11900000000000001;Q4;11;46;140;766;12;140;0.14;16,65;India;SPB Pharma Society;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
705;20572;PZ Prisma;journal;09455566;0.11900000000000001;Q4;5;36;103;514;7;91;0.08;14,28;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
706;21100205709;International Journal of Toxicological and Pharmacological Research;journal;09755160;0.11800000000000001;Q4;8;23;23;660;3;23;0.13;28,70;Australia;International Journal of Toxicological and Pharmacological Research;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
707;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.11800000000000001;Q4;6;28;57;338;5;52;0.10;12,07;India;Punjab Academy of Forensic Medicine and Toxicology;2011-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
708;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.11699999999999999;Q4;6;13;105;1049;30;105;0.32;80,69;New Zealand;Libertas Academica;2010-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
709;21100199794;Industrial Pharmacy;trade journal;17414911;0.11699999999999999;Q4;4;19;40;102;8;40;0.20;5,37;United Kingdom;Euromed Communications Ltd;2011-ongoing;Pharmaceutical Science (Q4)
710;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.11699999999999999;Q4;10;0;14;0;5;13;0.00;0,00;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
711;22338;Hospital Pharmacy;journal;00185787;0.11599999999999999;Q4;21;138;440;1913;42;381;0.12;13,86;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
712;23107;Journal of Pharmacy Technology;journal;87551225;0.11599999999999999;Q4;9;41;103;1089;12;102;0.06;26,56;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q4)
713;19700201509;Pharma Research;journal;09758216;0.11599999999999999;Q4;4;29;71;703;8;70;0.11;24,24;India;Sudarshan Publications;2011-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
714;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.11599999999999999;Q4;12;0;230;0;18;207;0.09;0,00;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
715;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.115;Q4;7;105;273;594;11;263;0.05;5,66;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
716;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.115;Q4;5;42;112;388;10;97;0.13;9,24;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
717;19200156912;EJHP Practice;journal;20303769, 17819989;0.114;Q4;5;0;166;0;20;138;0.19;0,00;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
718;19700175039;Open Toxicology Journal;journal;18743404;0.113;Q4;5;6;10;150;5;10;0.00;25,00;United Arab Emirates;Bentham Science Publishers;2009-2013;Toxicology (Q4)
719;22358;U.S. Pharmacist;journal;01484818;0.113;Q4;7;141;462;2343;33;393;0.06;16,62;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
720;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.11199999999999999;Q4;5;26;16;788;1;16;0.06;30,31;Iran;Kermanshah University of Medical Sciences;2012-ongoing;"Biomedical Engineering (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
721;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.11199999999999999;Q4;6;0;45;0;6;42;0.14;0,00;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
722;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.111;Q4;4;35;94;1016;4;92;0.07;29,03;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
723;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.111;Q4;2;3;147;0;4;96;0.05;0,00;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
724;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.111;Q4;14;18;71;463;2;71;0.00;25,72;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
725;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.111;Q4;5;11;2;181;1;2;0.50;16,45;India;In-IJPQA;2011, 2013-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
726;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0.111;Q4;3;2;6;57;2;6;0.33;28,50;Netherlands;Bentham Science Publishers B.V.;2011-2013;"Economics, Econometrics and Finance (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
727;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.111;Q4;5;8;34;159;1;34;0.04;19,88;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
728;25197;Revista de Toxicologia;journal;16970748, 02127113;0.111;Q4;9;16;50;498;2;49;0.06;31,13;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
729;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.11;Q4;7;0;55;0;8;55;0.07;0,00;Nigeria;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
730;21142;Pharmaceutisch Weekblad;journal;00316911;0.11;Q4;9;406;1254;673;17;957;0.02;1,66;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
731;9100153105;Current Topics in Pharmacology;journal;09724559;0.109;Q4;4;16;35;1240;2;35;0.00;77,50;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
732;19700175108;Drug Delivery System;journal;09135006;0.109;Q4;7;29;84;798;7;84;0.09;27,52;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
733;19700174940;SA Pharmaceutical Journal;journal;10151362;0.109;Q4;6;110;491;812;10;274;0.04;7,38;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q4)
734;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.10800000000000001;Q4;13;139;420;3092;19;420;0.04;22,24;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
735;19700174922;Chinese Journal of New Drugs;journal;10033734;0.10800000000000001;Q4;9;587;1415;9689;81;1415;0.06;16,51;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
736;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0.107;Q4;12;68;202;1554;10;202;0.05;22,85;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
737;4700152278;Drugs in Context;journal;17404398, 17451981;0.107;Q4;12;13;3;461;0;3;0.00;35,46;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
738;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.107;Q4;9;75;358;0;25;338;0.08;0,00;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacy (Q4)"
739;21127;Pharmaceutical Technology Europe;journal;17537967;0.107;Q4;16;75;319;305;21;238;0.09;4,07;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q4)
740;17716;Quality Assurance Journal;journal;10991786, 10878378;0.107;Q4;7;0;24;0;3;22;0.18;0,00;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
741;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.106;Q4;17;133;291;2222;13;275;0.04;16,71;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
742;19700201609;Open Natural Products Journal;journal;18748481;0.105;Q4;3;3;6;121;1;6;0.17;40,33;Netherlands;Bentham Science Publishers B.V.;2011-2014;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
743;21102;Pharmaceutical Journal;journal;00316873;0.105;Q4;25;0;2325;0;38;877;0.03;0,00;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
744;19700174966;Pharmakeftiki;journal;11054999;0.105;Q4;2;15;16;554;2;14;0.17;36,93;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
745;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.10400000000000001;Q4;4;136;356;2579;13;356;0.04;18,96;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
746;21823;Farmatsija;journal;04280296;0.10400000000000001;Q4;5;16;33;729;2;33;0.08;45,56;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
747;19700175034;Pharmaceutical Processing;trade journal;10499156;0.10400000000000001;Q4;2;57;210;96;2;91;0.04;1,68;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
748;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.10400000000000001;Q4;2;0;5;0;0;5;0.00;0,00;Russian Federation;SRL Archive;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
749;25196;Revista Brasileira de Toxicologia;journal;14152983;0.10400000000000001;Q4;6;0;6;0;0;6;0.00;0,00;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
750;22887;Chinese Journal of Antibiotics;journal;10018689;0.10300000000000001;Q4;10;161;528;2766;19;525;0.04;17,18;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
751;20628;Circular Farmaceutica;journal;00097314;0.10300000000000001;Q4;2;30;89;418;3;76;0.04;13,93;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
752;21238;Drug Topics;journal;00126616;0.10300000000000001;Q4;7;227;742;86;6;97;0.05;0,38;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
753;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.10300000000000001;Q4;5;59;175;456;4;173;0.02;7,73;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
754;21867;Geneesmiddelenbulletin;journal;03044629;0.10300000000000001;Q4;6;59;179;771;7;81;0.09;13,07;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
755;21100202747;GMP Review;trade journal;14764547;0.10300000000000001;Q4;2;16;40;31;2;39;0.05;1,94;United Kingdom;Euromed Communications Ltd;2011-2015;Pharmaceutical Science (Q4)
756;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;15830012;0.10300000000000001;Q4;3;0;102;0;8;100;0.08;0,00;Romania;Rp Publishing House;2011-2012, 2014-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
757;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.102;Q4;4;3;57;109;4;47;0.09;36,33;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
758;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.102;Q4;3;27;67;518;5;64;0.09;19,19;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
759;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;11;4;14;0;0;10;0.00;0,00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
760;19700169211;Life Science Clusters;trade journal;17528119;0.102;Q4;0;0;11;0;0;10;0.00;0,00;United Kingdom;Avakado Limited;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
761;20543;Pharmacometrics;journal;03008533;0.102;Q4;6;0;53;0;3;53;0.10;0,00;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
762;21243;Pharmacy times;trade journal;00030627;0.102;Q4;8;334;703;1608;10;414;0.02;4,81;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
763;21100201517;RSC Drug Discovery Series;book series;20413203;0.102;Q4;7;0;12;0;0;11;0.00;0,00;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery (Q4)
764;19700194018;Russian Journal of Biopharmaceuticals;journal;20738099;0.102;Q4;4;36;65;525;6;64;0.09;14,58;Russian Federation;Folium Publishing Company;2011-ongoing;"Bioengineering (Q4); Drug Discovery (Q4)"
765;21100229846;2010 International Symposium on Waterborne Pathogens;conference and proceedings;00002010;0.10099999999999999;-;1;0;33;0;0;32;0.00;0,00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
766;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.10099999999999999;Q4;9;27;23;145;1;14;0.00;5,37;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
767;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.10099999999999999;Q4;9;0;17;0;0;17;0.00;0,00;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
768;21100228007;Archives of Razi Institute;journal;03653439;0.10099999999999999;Q4;5;24;24;650;1;24;0.04;27,08;Iran;Razi Vaccine and Serum Research Institute;2012-ongoing;"Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
769;21100229867;AWWA 2010 Inorganic Contaminants Workshop;conference and proceedings;00002010;0.10099999999999999;-;1;0;29;0;0;28;0.00;0,00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
770;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.10099999999999999;Q4;3;9;97;43;2;71;0.06;4,78;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
771;19700174996;European Life Science Journal;trade journal;20001444;0.10099999999999999;Q4;1;0;51;0;0;34;0.00;0,00;Thailand;The Psychiatric Association of Thailand;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
772;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0.10099999999999999;Q4;6;0;15;0;0;14;0.00;0,00;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
773;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.10099999999999999;Q4;5;234;754;3823;14;754;0.02;16,34;China;Jilin University;2005-ongoing;Pharmacology (Q4)
774;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.10099999999999999;Q4;7;0;21;0;0;21;0.00;0,00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
775;13637;Manufacturing Chemist;journal;02624230;0.10099999999999999;Q4;6;138;347;275;2;316;0.00;1,99;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
776;21077;Pharmaca;journal;00316857;0.10099999999999999;Q4;4;0;30;0;0;26;0.00;0,00;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
777;19700175002;Pharmaceutical Reviews;journal;19185561;0.10099999999999999;Q4;4;0;25;0;0;25;0.00;0,00;India;PharmaInfo Publications;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
778;21100208082;VacciMonitor;journal;10250298, 1025028X;0.10099999999999999;Q4;3;24;22;451;0;21;0.00;18,79;Cuba;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-ongoing;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
779;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.1;Q4;2;0;68;0;1;58;0.05;0,00;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
780;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.1;Q4;6;0;113;0;0;113;0.00;0,00;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
781;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.1;Q4;3;122;243;2977;3;240;0.01;24,40;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
782;19700173109;Contract Pharma;trade journal;15443469;0.1;Q4;3;143;462;190;4;388;0.01;1,33;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
783;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;51;200;208;1;192;0.01;4,08;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
784;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0.1;Q4;3;0;99;0;4;98;0.00;0,00;Poland;Medical University of Silesia;2010-2011;Pharmaceutical Science (Q4)
785;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.1;Q4;8;0;63;0;1;63;0.00;0,00;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
786;19700175602;Next Generation Pharmaceutical;trade journal;-;0.1;Q4;1;0;112;0;0;57;0.00;0,00;United Kingdom;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
787;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135;0.1;Q4;1;0;137;0;0;131;0.00;0,00;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-2012;Pharmaceutical Science (Q4)
788;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;53;208;82;1;205;0.01;1,55;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
789;19700175580;PharmacoVigilance Review;journal;17526752;0.1;Q4;1;9;66;32;1;44;0.00;3,56;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
790;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;0;244;0;0;93;0.00;0,00;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
791;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;5;0;157;0;1;107;0.00;0,00;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
792;16800154712;Sp2;trade journal;1476184X;0.1;Q4;1;51;146;29;0;130;0.00;0,57;United Kingdom;Manor Creative;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
793;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.1;Q4;12;160;118;1772;1;108;0.02;11,08;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
794;21100841779;ADMET and DMPK;journal;18487718;;-;9;8;0;237;0;0;0.00;29,63;Croatia;International Association of Physical Chemists;2017-ongoing;"Chemistry (miscellaneous); Health (social science); Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
795;21100256959;Biomarkers and Genomic Medicine;journal;22140247;;-;7;28;0;828;0;0;0.00;29,57;United States;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Biomedical Engineering; Drug Discovery; Medicine (miscellaneous)"
796;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;;-;13;100;0;7270;0;0;0.00;72,70;United Kingdom;Taylor & Francis;2013-ongoing;"Health Policy; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
797;21100241624;International Journal of Genomics;journal;2314436X, 23144378;;-;17;44;0;2112;0;0;0.00;48,00;Egypt;Hindawi Publishing Corporation;2013-ongoing;"Biochemistry; Genetics; Molecular Biology; Pharmaceutical Science"
798;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;;-;36;21;0;1042;0;0;0.00;49,62;United Kingdom;BioMed Central;2014-ongoing;"Cancer Research; Immunology; Immunology and Allergy; Molecular Medicine; Oncology; Pharmacology"
799;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;;-;5;5;0;186;0;0;0.00;37,20;Chile;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-ongoing;"Drug Discovery; Pharmaceutical Science; Pharmacology"
800;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;249;754;5818;302;754;0.40;23,37;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
801;21100348334;Pharmaceutical Discovery, Development and Manufacturing Forum 2013 - Core Programming Area at the 2013 AIChE Annual Meeting: Global Challenges for Engineering a Sustainable Future;conference and proceedings;00002013;;-;1;74;0;120;0;0;0.00;1,62;United States;;2013;"Organic Chemistry; Pharmaceutical Science"
802;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;;-;2;606;0;762;0;0;0.00;1,26;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology; Pharmacology (medical)"
803;21100825823;Pharmacology Research and Perspectives;journal;20521707;;-;20;16;0;635;0;0;0.00;39,69;United Kingdom;Wiley-Blackwell Publishing Ltd;2013-ongoing;"Neurology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
804;21100239265;PharmaNutrition;journal;22134344;;-;14;26;0;1387;0;0;0.00;53,35;Netherlands;Elsevier BV;2013-ongoing;"Food Science; Pharmacology; Pharmacology (medical)"
805;21100784233;Proceedings of the 2013 21st Euromicro International Conference on Parallel, Distributed, and Network-Based Processing, PDP 2013;conference and proceedings;00002013;;-;0;1;0;8;0;0;0.00;8,00;United States;;2013;"Pharmaceutical Science; Statistics and Probability"
806;21100830708;Toxics;journal;23056304;;-;12;7;0;265;0;0;0.00;37,86;Switzerland;MDPI AG;2017-ongoing;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
807;21100335701;Vaccines;journal;2076393X;;-;24;1;0;195;0;0;0.00;195,00;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Drug Discovery; Immunology; Infectious Diseases; Pharmacology; Pharmacology (medical)"
